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Zusammenfassung
N-Methyl-D-Aspartat-Rezeptoren (NMDARen), die eine wichtige Rolle bei Lern-
und Gedächtnisprozessen spielen, aber auch für bestimmte neurologische Störun-
gen verantwortlich sind, sind heterotetramere Komplexe, die aus zwei NR1- und
zwei NR2-Untereinheiten bestehen. Die Rolle synaptischer NMDARen in postnata-
len Prinzipalneuronen im Vorderhirn wird entgegen zwingenden Beweisen für trihe-
teromere NR1/NR2A/NR2B-Rezeptoren in der Regel diheteromeren NR1/NR2A-
und NR1/NR2B-Rezeptoren zugeschrieben. In hippokampalen CA1-Synapsen konn-
ten die Eigenschaften triheteromerer Rezeptoren bislang nicht von denjenigen di-
heteromerer NMDAR-Mischungen unterschieden werden. Um NR1/NR2A/NR2B-
Rezeptoren charakteristische Eigenschaften zuzuweisen, wurden in der vorliegen-
den Arbeit zwei verschiedene, jeweils ausschließlich reine NR1/NR2A- oder
NR1/NR2B-Rezeptorpopulationen exprimierende, NR2 knockout-Mauslinien ein-
gesetzt und deren synaptische Eigenschaften mit denen der Wildtyp-Mäuse vergli-
chen. Es stellte sich heraus, dass die beiden diheteromeren NMDAR-Subtypen in
akuten hippokampalen Schnitten adulter Mäuse eine unterschiedliche Spannungs-
abhängigkeit der Deaktivierungskinetik aufwiesen. Bei Wildtyp-Mäusen vergleich-
baren Alters konnten wir nur die NR1/NR2A-charakteristische Spannungsabhän-
gigkeit der Deaktivierungskinetik beobachten. Dies bedeutet, dass NR1/NR2B-
Rezeptoren nur eine kleine Population in adulten CA3-CA1-Synapsen ausmachen.
Stattdessen trat das Vorhandensein von NR1/NR2A/NR2B-Rezeptoren aufgrund
einer langsameren Deaktivierungskinetik der NMDA-Ströme (NMDA EPSCs) als
derjenigen der reinen NR1/NR2A-Rezeptoren deutlich hervor. Darüber hinaus un-
tersuchten wir den Effekt von NR2B-Untereinheit-bindenden NMDAR-Antagonis-
ten auf NMDA EPSCs in der Abwesenheit von extrazellulärem Mg2+, was die
Sensitivität der Antagonisten, insbesondere für NR1/NR2A/NR2B-Rezeptoren,
stark verbesserte. Der Effekt dieser Antagonisten auf NMDA EPSCs war stark
bei P5 und blieb bei circa 50 % bei P28. Folglich ist die NR2B-Untereinheit in
hippokampalen Synapsen während der gesamten Entwicklung von Bedeutung und
wird in adulten Mäusen in Form von NR1/NR2A/NR2B-Rezeptoren bewahrt.
Summary
N-methyl-D-aspartate receptors (NMDARs), fundamental to learning and memory
and implicated in certain neurological disorders, are heterotetrameric complexes
composed of two NR1 and two NR2 subunits. The role of synaptic NMDARs
in postnatal principal forebrain neurons is typically attributed to diheteromeric
NR1/NR2A and NR1/NR2B receptors, despite compelling evidence for trihetero-
meric NR1/NR2A/NR2B receptors. In hippocampal CA1 synapses, the proper-
ties of triheteromeric NMDARs could thus far not be distinguished from those of
mixtures of diheteromeric NMDARs. To find a signature of NR1/NR2A/NR2B
receptors, we have employed two gene-targeted mouse lines, expressing either
NR1/NR2A or NR1/NR2B receptors without any NR1/NR2A/NR2B receptors,
and compared their synaptic properties to those of wild type. We found in acute
hippocampal slices of adult mice a distinct voltage dependence of NMDA EPSC
decay time for the two diheteromeric NMDARs. In age-matched wild-type mice,
only the NR1/NR2A characteristic for this voltage-dependent deactivation could
be detected, indicating that NR1/NR2B receptors are a minor population in adult
CA3-to-CA1 synapses. Instead, the presence of NR1/NR2A/NR2B receptors be-
came manifest from a slower NMDA EPSC decay time than for NR1/NR2A
receptors. Moreover, we examined the sensitivity of NMDA EPSCs to NR2B-
directed NMDAR antagonists in the absence of extracellular Mg2+, which improved
the sensitivity of these antagonists, especially for NR1/NR2A/NR2B receptors.
NMDA EPSC sensitivity to NR2B-directed NMDAR antagonists was high at P5
and remained around 50% at P28. Thus, NR2B is prominent in hippocampal
synapses throughout life and remains present in adult mice as an integral part of
NR1/NR2A/NR2B receptors.
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11 Introduction
1.1 Signal transmission in the central nervous
system
The nervous system is an organ system consisting of a network of nerve cells (neu-
rons) and glial cells. It receives incoming information about the organism and the
environment, which is further processed in order to trigger an appropriate action.
In most animals, the nervous system consists of two parts, central and peripheral.
The central nervous system (CNS) integrates incoming stimuli, originating either
from the organism itself or from the environment, it coordinates all motor action
and regulates the communication between different organs and systems. In hu-
mans and all other vertebrates, the CNS comprises the brain and the spinal cord.
The human brain consists of 1011 neurons and 10 times more glia. In the classical
view, glial cells have been considered to play simple supportive roles for neurons.
They were thought to provide the brain with structure, sometimes insulate neu-
ronal groups and synaptic connections from each other. Certain classes of glial
cells guide migrating neurons and direct axonal outgrowth. Furthermore, they
help to form the blood-brain-barrier, remove cellular debris and secrete trophic
factors. However, this view of glia representing only passive bystanders of the
neural transmission has changed, since recent research indicates that glial cells
participate in synaptic transmission, are able to modulate synaptic strength, and
even release neurotransmitters (Haydon and Carmignoto, 2006; Henneberger et
al., 2010; Perea and Araque, 2009). But, although the dogma that synaptic func-
tion results exclusively from signaling between neurons as the only excitable cells
has been challenged by the finding that glial cells can also fire action potentials
(Káradóttir et al., 2008), the signaling by neurons is still indispensable.
Neurons are classically divided into two functional classes: principal (or pro-
jection) neurons and interneurons. Principal neurons, possessing long-distance
projections, convey information from organs and tissues to the CNS (afferent neu-
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rons), or transmit signals from the CNS to the effector cells (efferent neurons) that
can be located in other networks within the CNS or in tissues outside the CNS,
like e.g. muscles. Principal neurons can be either excitatory with glutamate as the
most important excitatory neurotransmitter, or inhibitory. In contrast to princi-
pal neurons, interneurons are only locally projecting and connect neurons involved
in the same processing state within specific regions of the CNS. Interneurons are
often inhibitory and use the neurotransmitters GABA or glycine. Inhibitory neu-
rons control spike timing of principal neurons, synaptic plasticity, and network
oscillations (Bonifazi et al., 2009; Buzsáki and Chrobak, 1995; Paulsen and Moser,
1998; Whittington and Traub, 2003).
Although neurons are very diverse and show different sizes and morphologies
depending on their function and location, a schematic description of the structure
and function of a ‘typical’ neuron can be given (Fig. 1). A typical neuron is divided
into three parts: soma or cell body, dendrites, and axon. The soma contains
the nucleus and other organelles important for protein synthesis and homeostasis.
Multiple dendrites extrude from the soma and branch multiple times, giving rise to
the dendritic tree. Neurons receive input from other neurons over the dendrites,
which often exhibit small protrusions, called spines. Signals to other neurons
are transmitted by the axon, the output structure of the neuron. It arises from
a swelling of the soma, the axon hillock, and also shows extensive branching.
The structures contacting other neurons are typically the presynaptic terminals or
boutons, which appear as a thickening at the end of the axon. The contact between
the axonal bouton of one neuron, called presynaptic neuron, and the dendritic spine
or another part of the other, postsynaptic neuron, is called ‘synapse’.
Neuronal communication or synaptic transmission can take place either elec-
trically or chemically. Electrical signaling is fast and without latency, because
at electrical synapses signals are transmitted by direct exchange of ions via gap
junctions which form a contact between the pre- and the postsynaptic neuron. In
contrast, at chemical synapses, the pre- and postsynaptic neurons are separated
by the synaptic cleft and therefore electrically isolated. Here, signal transmission
requires neurotransmitter release and diffusion, making chemical signaling slower
compared to electrical signaling.
The special feature of neurons, enabling them to the reception and transmission
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Fig. 1: Morphology of neurons.
The cell body contains nucleus and
perikaryon, and gives rise to two
types of processes: dendrites and
axon. Axons, the transmitting el-
ements of neurons, can vary greatly
in length. The axon hillock is the
site at which the action potential
is initiated. Many axons are insu-
lated by a myelin sheath that is in-
terrupted at regular intervals by re-
gions known as nodes of Ranvier.
Branches of the axon of one neuron
(the presynaptic neuron) transmit
signals to another neuron (the post-
synaptic neuron) at a site called
synapse. The branches of a sin-
gle axon may form synapses with
as many as 1000 other neurons
(adapted from Kandel et al., 2000).
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of signals, is their electrical excitability. A combination of special ion channels and
metabolically driven ion pumps maintains a voltage-gradient across the semiper-
meable membrane by intracellular-versus-extracellular concentration differences of
ions such as Na+, K+, Ca2+, and Cl−. The resting membrane potential ranges typ-
ically from −80 mV to −60 mV, depending on the cell type. If the membrane is
depolarized by excitatory inputs and reaches a certain membrane potential thresh-
old (typically −40 mV), an action potential, which is an all-or-none event and has
a stereotyped shape, is generated. The ability of neurons to generate an action
potential, a regenerative electrical output signal, is the basis of signal transmis-
sion in the CNS. The action potential is initiated in the axon hillock and then
spreads along the axon without attenuation. Additionally, it propagates back into
the dendrites and therefore provides a retrograde signal of neuronal output to
the dendritic tree. Reason for the generation and specific properties of the ac-
tion potential is the presence of diverse ion channels in the plasma membrane,
mainly of voltage-activated Na+ and K+ channels. As soon as excitatory stim-
uli depolarize the negative resting membrane potential above a certain threshold,
voltage-activated Na+ channels have a higher open probability. The opening of
these voltage-activated Na+ channels results in further depolarization by an in-
flux of Na+ ions, and the membrane potential is driven towards the equilibrium
potential for Na+ (around +50 mV). Before the maximum membrane potential is
reached, the voltage-activated Na+ channels rapidly inactivate. Voltage-activated
K+ channels have a similar threshold as voltage-activated Na+ channels, but their
opening is much slower, so that they reach their maximum when most of the
voltage-activated Na+ channels are already inactivated. This leads to an K+ out-
flow and repolarizes the cell membrane. Action potential propagation along the
axon can either be continuous, as for non-myelinated axons, or saltatory, as for
myelinated axons. In non-myelinated axons, an action potential depolarizes the
surrounding membrane, so that the threshold is reached and a new action potential
is generated in the vicinity of the primary action potential. This spread of exci-
tation is relatively slow (most of the times only 1-3 m/s, at maximum 30 m/s).
In vertebrates, most of the axons are myelinated. The myelin sheath is formed by
glial cells and is interrupted at regular intervals by regions called nodes of Ranvier.
The isolation by the myelin sheath markedly accelerates the speed of conduction.
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The positive charges spread along the axon, and the amplitude of the initial action
potential is regenerated at the nodes of Ranvier, which constitute the only places
where action potentials can be generated along the myelinated axon.
When an action potential arrives at the presynaptic terminal, voltage-sensitive
Ca2+ channels open. The subsequent Ca2+ influx binds to proteins that trigger the
fusion of neurotransmitter-filled presynaptic vesicles with the plasma membrane.
The neurotransmitter is released into the synaptic cleft and diffuses across the
synaptic cleft to the postsynaptic membrane. There, it binds to postsynaptic
receptors leading to opening or closing of ion channels, and thereby altering the
membrane conductance and potential of the postsynaptic cell.
Receptors can be of two different types, ionotropic or metabotropic. Ionotropic
receptors are transmembrane ion channels that open or close in response to the
binding of a neurotransmitter and mediate fast synaptic transmission in the mil-
lisecond range. In contrast, metabotropic receptors do not form an ion channel,
but are indirectly linked with ion channels through signal transduction mecha-
nisms, using G-proteins as second messengers. Therefore, they act on a slower
time scale in a second-to-minute range.
Synaptic transmission in the CNS can be either excitatory or inhibitory, depend-
ing on the released neurotransmitter and the activated receptors. Glutamate is the
predominant chemical transmitter of excitatory synapses (Curtis et al., 1959), and
receptors for this ubiquitous neurotransmitter are divided into two classes: iono-
tropic and metabotropic. Ionotropic glutamate receptors (iGluRs) are classified
as L-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), kainate and
N-methyl-D-aspartate (NMDA) receptors, based on their responsiveness to cer-
tain glutamate derivatives. All three types mediate a depolarizing current causing
an excitatory postsynaptic potential (EPSP), but the speed and duration of the
excitatory postsynaptic current (EPSC) is different for each type. The ionotropic
glutamate receptors will be described in detail in the following section. In con-
trast to ionotropic glutamate receptors that always mediate an excitatory effect,
metabotropic glutamate receptors can produce either excitation or inhibition, de-
pending on the coupled G-protein.
The main inhibitory neurotransmitters in the CNS are glycine and γ-aminobutyric
acid (GABA). GABA receptors are divided into ionotropic GABAA receptors and
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metabotropic GABAB receptors. GABAA receptors form Cl− and HCO3− per-
meable channels which open upon GABA binding. The resulting anion influx,
consisting mainly of Cl−, mediates an inhibitory postsynaptic potential (IPSP)
and rapidly hyperpolarizes the membrane. GABAB receptors can either activate
K+ channels or inhibit voltage-dependent Ca2+ channels.
The depolarizing and hyperpolarizing signals generated on the postsynaptic
membrane at different excitatory and inhibitory connections spread along the den-
dritic tree. EPSPs and IPSPs are integrated and are either sub- or suprathreshold
for the generation of an action potential.
1.2 Ionotropic glutamate receptors
1.2.1 Classification of ionotropic glutamate receptors
Most of the excitatory neurotransmission in the CNS is mediated by iGluRs. All
iGluRs are ligand-gated, nonselective cation channels that are permeable for Na+,
K+, and sometimes Ca2+ upon glutamate binding. Activation of iGluRs always
leads to an EPSP, but the speed and duration of the underlying current (EPSC)
is different for AMPA, kainate, and NMDA receptors, respectively. AMPA and
kainate receptors, collectively termed as non-NMDARs, are responsible for a fast
ionic inward current thereby contributing to the early peak of the EPSC. In
contrast, NMDARs activate and deactivate relatively slowly compared to non-
NMDARs and contribute mainly to the late phase of the EPSC (Mayer and West-
brook, 1987b). AMPARs form heteromeric complexes of the subunits GluR-A
to GluR-D (GluA-1 to GluA-4), kainate receptors are subdivided into GluR-5 to
GluR-7, KA-1, and KA-2 (GluK-1 to GluK-5) (Hollmann and Heinemann, 1994).
The NMDAR subunits will be described in detail in the following sections. One
additional family of the iGluRs, termed delta, was identified, but a functional pro-
file has not been determined yet (Yamazaki et al., 1992). The two members of
this class, δ1 and δ2, share 18 to 25 % sequence homology with the other iGluR
subunits, but remain orphan subunits (Araki et al., 1993; Lomeli et al., 1993).
Nevertheless, they seem to play important roles in the CNS, in particular in the
cerebellum (Yuzaki, 2004; Zuo et al., 1997).
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1.2.2 Structure of ionotropic glutamate receptors
iGluRs presumably assemble as tetramers in a dimer-of-dimers structure (Kim et
al., 2010; Laube et al., 1998; Rosenmund et al., 1998; Sobolevsky et al., 2009):
NMDARs are obligate heteromers (Monyer et al., 1992), whereas AMPA and
kainate receptors can form functional homomeric complexes (Boulter et al., 1990),
although in native tissues they have been shown to form almost exclusively het-
erotetramers (Christensen et al., 2004; Lu et al., 2009; Mulle et al., 2000). The
specific subunit composition determines not only the biophysical properties of
the GluR channel, but also its trafficking during basal synaptic transmission and
synaptic plasticity (Barria and Malinow, 2002; Barry and Ziff, 2002). Although
iGluRs are divergent with respect to function, electrophysiological profile, ion per-
meability, expression pattern, and trafficking, they are related in amino acid se-
quence and have a common structural design (Fig. 2). Each subunit comprises four
modules (Wo and Oswald, 1995): the extracellular amino-terminal domain (NTD)
participates in subtype-specific receptor assembly, trafficking, and modulation (Ay-
alon and Stern-Bach, 2001); the adjacent ligand-binding domain (LBD) is central
to agonist binding and to activation gating (Stern-Bach et al., 1994). A trans-
membrane domain forms the ion channel (Wollmuth and Sobolevsky, 2004), and a
cytoplasmic carboxy-terminal domain (CTD) influences receptor function, signal-
ing, and trafficking (Barry and Ziff, 2002; Soderling and Derkach, 2000; Sprengel
and Single, 1999). Each individual subunit consists of three transmembrane do-
mains (M1, M3, M4) plus a cytoplasm-facing re-entrant loop (M2). The ligand-
binding site consists of two globular domains (S1 and S2), that are formed by
the sequence preceding the M1 domain and the M3-M4 loop. The S1 and S2
domains form a clamshell-like structure that undergoes a conformational change
upon ligand binding (Dingledine et al., 1999; Stern-Bach et al., 1994). Residues
in the re-entrant second membrane loop control key permeation properties of the
ion channel (Wollmuth and Sobolevsky, 2004). The M2 region is thought to be in-
volved in lining the channel pore and contains the functionally crucial Q/R/N site
at its tip. The amino acid residues located at the Q/R/N sites most probably face
the ion permeation pathway to form part of the selectivity filter in GluR channels
(Burnashev, 1996). The Q/R/N site of the M2 segment is occupied by a glutamine
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Fig. 2: Topology of iono-
tropic glutamate receptors. In-
dividual glutamate receptor sub-
unit with four hydrophobic seg-
ments, of which M1, M3, and M4
are membrane-spanning domains,
whereas M2 forms a cytoplasm-
facing re-entrant loop. The aster-
isk indicates the Q/R/N site. The
S1 and S2 lobes form the ligand-
binding domain (S1S2 complex, in-
dicated by a broken line). The large
extracellular NTD and intracellu-
lar CTD are not shown to scale
(adapted and modified from Woll-
muth and Sobolevsky, 2004).
(Q) or an arginine (R) residue in non-NMDARs and by an asparagine (N) residue
in NMDARs. The Q/R/N site is also a site prone to RNA editing in AMPA and
kainate receptors, with the GluR-B Q/R site being the most vigorously edited site
(Higuchi et al., 1993; Sommer et al., 1991). Presence of edited or non-edited GluR-
B in the heteromeric AMPAR channel determines the divalent ion permeability,
e.g. Ca2+ (Burnashev et al., 1992a; Hume et al., 1991). Furthermore, the Q/R/N
site affects single channel conductance and blockade by intracellular polyamines
(Hume et al., 1991; Swanson et al., 1996). Thus, residues of the Q/R/N site con-
stitute a common structural motif of the iGluR’s M2 segment and influence some
of their selectivity and conductance properties.
1.3 NMDA receptors
1.3.1 Role of NMDA receptors during synaptic transmission
and plasticity
In neurons, NMDARs have been detected at both pre- and postsynaptic sites (Tzin-
gounis and Nicoll, 2004). In GABAergic interneurons, NMDARs appear to be dis-
tributed along the smooth dendritic shafts, whereas in the postsynaptic membrane
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of excitatory neurons, the density of NMDARs is higher in spines, within the post-
synaptic density (PSD), than in the dendritic shaft and the somatic membrane.
Among iGluRs, NMDARs have a unique function. For complete activation, they
require simultaneous binding of an agonist and a coagonist, which can be either
glycine or D-serine (Johnson and Ascher, 1987; Kleckner and Dingledine, 1988;
Wolosker et al., 1999). The NMDAR pore is controlled in a voltage-dependent
manner: at resting membrane potential, the receptor channel is blocked by Mg2+
and becomes unblocked due to depolarization (Nowak et al., 1984). The voltage-
dependent Mg2+ block suites NMDARs to detect coincident presynaptic release of
glutamate and postsynaptic depolarization. NMDARs are therefore coincidence
detectors of pre- and postsynaptic activity. NMDARs are highly permeable to
Ca2+, so that under physiological conditions, Ca2+ constitutes ∼10% of the to-
tal NMDAR-mediated current (Burnashev et al., 1995; Jahr and Stevens, 1993;
Mayer and Westbrook, 1987a; Schneggenburger et al., 1993). This Ca2+ influx can
trigger intracellular signaling cascades leading to long-term potentiation (LTP) or
long-term depression (LTD), which are thought to underlie memory acquisition
and learning (Bliss and Collingridge, 1993; Dudek and Bear, 1992). Thus, the
function of NMDARs is related to the induction of synaptic plasticity and to var-
ious forms of learning and memory. Furthermore, NMDARs are essential to the
establishment and modification of synapses during development (Bear et al., 1990;
Iwasato et al., 2000; Ramoa et al., 2001), but they are also involved into several
pathophysiological processes (Cull-Candy et al., 2001; Meldrum, 1992; Rothman
and Olney, 1995).
Activation of NMDARs can last for several hundred milliseconds (Hestrin et al.,
1990; Lester et al., 1990). In comparison to non-NMDARs, which exhibit kinet-
ics of activation1, deactivation2, and desensitization3 on a millisecond timescale
(Hansen et al., 2007), NMDARs show prolonged channel activity. The kinetic
properties of NMDARs will be described in detail in section 1.3.5.
1opening of the receptor in the presence of agonist
2unbinding of agonist and closure of the channel
3closure of the channel with agonist bound
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1.3.2 NMDA receptor subunits
To date, three gene families encoding for NMDARs have been identified: NR1,
NR2 (A, B, C, D), and NR3 (A, B). NR1 and NR3A subunits have been described
to undergo alternative splicing, which leads to further subclasses of several iso-
forms (Ciabarra et al., 1995; Moriyoshi et al., 1991; Nishi et al., 2001; Sasaki et
al., 2002; Sucher et al., 1995; Sugihara et al., 1992; Sun et al., 1998). To form a
functional NMDAR channel, two glycine/serine-binding NR1 and two glutamate-
binding NR2 subunits presumably form heterotetrameric NR1/NR2 complexes
composed of two diagonal heterodimers (Furukawa et al., 2005; Sobolevsky et al.,
2009). In addition to these conventional NMDARs with known specific properties,
NR1 and NR3 subunits can coassemble and form excitatory glycine receptors.
By itself, glycine is usually thought of as an inhibitory neurotransmitter. How-
ever, NR1/NR3 receptors form excitatory glycine receptors that are insensitive to
glutamate, Ca2+ impermeable, and resistant to Mg2+ (Chatterton et al., 2002).
NR3A and NR3B differ with respect to their regional and developmental expres-
sion (Chatterton et al., 2002; Ciabarra et al., 1995; Fukaya et al., 2005; Sucher et
al., 1995; Wong et al., 2002). Both NR3 subunits modulate NR1/NR2 heteromers
by reducing current responses (Ciabarra et al., 1995; Das et al., 1998; Sasaki et al.,
2002; Sucher et al., 1995), probably by assembling of NR1, NR2, and NR3 subunits
into triheteromeric NR1/NR2/NR3 receptors (Cavara and Hollmann, 2008). It is
still unclear whether the presence of NR3 results in a lower sensitivity to Mg2+
ions (Nishi et al., 2001; Sasaki et al., 2002; Sucher et al., 1995; Tong et al., 2008),
though coexpression of NR3 appears to decrease the Ca2+ permeability of conven-
tional NMDARs (Das et al., 1998; Matsuda et al., 2003, 2002; Pérez-Otaño et al.,
2001). Thus, the NR3 subunit gives rise to a class of NMDARs with distinct prop-
erties from the conventional NMDARs. The key characteristics usually ascribed
to NMDARs are determined by the conventional NMDARs, comprising two NR1
and two NR2 subunits. The NR2 subunits endow NMDARs with distinct bio-
physical and pharmacological properties, including deactivation, open probability,
strength of Mg2+ block, single-channel conductance, and sensitivity to extracel-
lular allosteric modulators (Cull-Candy and Leszkiewicz, 2004; Dingledine et al.,
1999).
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1.3.3 Developmental and spatial regulation of NMDA
receptor subtype expression
The NR1 subunit shows continuous and ubiquitous expression in the brain, whereas
expression of the four NR2 subunit genes, encoding NR2A-D, is temporally and
spatially regulated (Monyer et al., 1994; Watanabe et al., 1993). NR2B and NR2D
are present already during embryonic development, while expression of NR2A and
NR2C starts after birth in the forebrain and the cerebellum, respectively. In
hippocampal principal neurons, NR2D expression decreases postnatally and is
no longer expressed in adulthood, in contrast to NR2B. Accordingly, immuno-
gold labeling detected NR2A and NR2B in PSDs of adult CA1 pyramidal cells
(Köhr et al., 2003). Hence, the predominant NR2 subunits in the adult hip-
pocampus are NR2A and NR2B, giving rise to three different NMDAR subtypes:
diheteromeric NR1/NR2A and NR1/NR2B receptors, as well as triheteromeric
NR1/NR2A/NR2B receptors. Several studies suggested a higher content of NR2B-
containing receptors at extrasynaptic than at synaptic sites (Fellin et al., 2004;
Scimemi et al., 2004; Stocca and Vicini, 1998). In contrast, other studies have
shown that NR2B remains present within the synapse (Fujisawa and Aoki, 2003;
Janssen et al., 2005), and that NR2A-containing receptors are not only present
within the synapse, but also extrasynaptically (Li et al., 1998; Thomas et al.,
2006). This discrepancy indicates that the classification of NR2A as synaptic and
NR2B as extrasynaptic NMDARs subunits is not absolute and that both subunits
can be located either in synaptic or extrasynaptic compartments. Despite com-
pelling evidence for NR1/NR2A/NR2B receptors (Al-Hallaq et al., 2007; Chazot
et al., 1994; Kew et al., 1998; Luo et al., 1997; Sheng et al., 1994), the role of
synaptic NMDARs in postnatal principal forebrain neurons is typically attributed
to diheteromeric NR1/NR2A and NR1/NR2B receptors. The physiological roles of
NR1/NR2A/NR2B receptors are difficult to address because, thus far, a signature
of triheteromeric receptors allowing their distinction of mixtures of diheteromeric
NMDARs is still not manifest.
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1.3.4 Voltage-dependent Mg2+ block of NMDA receptors
The pore of the NMDAR channel is blocked by extracellular Mg2+ preventing ion
influx (Mayer et al., 1984; Nowak et al., 1984). This voltage-dependent Mg2+
block is one of the unique properties that determines the critical contribution of
NMDARs to CNS synaptic physiology. It imparts the receptor with the function of
a coincidence detector, sensing simultaneous pre- and postsynaptic activity, which
is a prerequisite for inducing input-specific, long-lasting changes in the strength of
synaptic connections (Bliss and Collingridge, 1993).
In the pore-lining M2 segment of the NR1 and NR2 subunits, asparagine (N)
residues occupy an identical position, called the N-site (Hollmann and Heinemann,
1994). In both subunits, these N-site asparagines are located at the tip of the loop
formed by the M2 segment. The narrowest part of the pore, the narrow constric-
tion or selectivity filter, is formed primarily by the N-site of the NR1 subunit and
the N+1 site of the NR2 subunit, designating an asparagine residue adjacent to
the N-site (Wollmuth et al., 1996). The narrow constriction forms a structural de-
terminant of the Mg2+ block (Burnashev et al., 1992b; Mori et al., 1992; Sakurada
et al., 1993). The critical blocking site for extracellular Mg2+ is formed by the
N-site and N+1 site of the NR2 subunit, and the contribution to the blocking site
is stronger for the N+1 site than for the N-site asparagine. Much of the voltage
dependence of the block is an intrinsic, local property of NR2 subunits at the nar-
row constriction. The N-site asparagine of the NR1 subunit contributes only little
to the block by extracellular Mg2+ (Wollmuth et al., 1998a), but it represents the
dominant blocking site for intracellular Mg2+. The physiological function of the
block by intracellular Mg2+ is unknown (Wollmuth et al., 1998b). In the following,
only the block by extracellular Mg2+ will be considered.
Subtype-specific differences of Mg2+ block are determined by the NR2 subunit.
Channels containing NR2A and NR2B are more sensitive to Mg2+ block compared
to NR2C- or NR2D-containing channels (Monyer et al., 1994). Consequently, cur-
rents mediated by NR1/NR2A and NR1/NR2B channels are more strongly reduced
by Mg2+ than currents mediated by NR1/NR2C and NR1/NR2D channels, pre-
dominantly reflecting a difference in voltage dependence. These subtype-specific
differences of Mg2+ block are determined by at least three amino acid clusters of
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the NR2 subunit, likely to be positioned close to the channel pore (Kuner and
Schoepfer, 1996).
1.3.5 Kinetic properties of NMDA receptors
Compared to non-NMDARs, NMDARs display high affinity to glutamate (McBain
and Mayer, 1994) and activate and deactivate much slower: they open at least one
order of magnitude more slowly (∼10 ms) and remain active for a long time (50-
500 ms), even when glutamate has already been removed from the synaptic cleft
(∼1 ms, Clements et al., 1992). For full receptor activation, NMDARs require
binding of two molecules of glutamate and two molecules of the coagonist (Ben-
veniste and Mayer, 1991; Clements and Westbrook, 1991). The deactivation time
course of these receptors is much longer than the dwell time of glutamate in most
synaptic clefts (Clements et al., 1992), and therefore determines the EPSC du-
ration. NMDAR currents decay with biphasic kinetics, meaning that the decay
is composed of a slow and a fast component (Lester et al., 1990). The underly-
ing kinetics of NMDAR gating responsible for the slow NMDA EPSC time course
are extremely complex. To understand and describe the parameters determining
the shape of NMDAR responses including activation, deactivation, and desensiti-
zation, different single-channel models have been developed considering different
states (conducting and nonconducting) as well as distinct activity patterns (kinetic
modes) of the receptor (Lester and Jahr, 1992; Popescu and Auerbach, 2004). The
hypothesis that the NMDAR decay kinetics are controlled by the unbinding rate
of transmitter has been supported by different studies (Colquhoun et al., 1977;
Pan et al., 1993), but more recently it has been proposed that the slow NMDAR-
mediated current decay does not arise from slow agonist dissociation per se, but
rather mainly from slow and frequent oscillations between fully liganded open and
closed conformations (Popescu and Auerbach, 2003). In addition, it has been
suggested that the biphasic decay largely reflects modal gating and that desensi-
tization has only a minor role (Zhang et al., 2008).
The deactivation of NMDARs is dependent on the subunit composition. De-
activation times are quite distinct for the diheteromeric NMDAR subtypes and
span a ∼50-fold range, exhibiting following order from the fastest to the slowest
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decay: NR2A < NR2B = NR2C  NR2D (Cull-Candy and Leszkiewicz, 2004;
Vicini et al., 1998). The developmental change of subunit expression in the brain
(see section 1.3.3) is often described to be related to changes in the NMDA EPSC
decay (Cull-Candy et al., 2001).
NMDARs desensitize in the continued presence of agonist: transmitter molecules
are bound with high affinity, but the channel remains closed. The desensitization
is slow and complex and involves at least three distinct processes (McBain and
Mayer, 1994). It has been described that NMDAR responses desensitize due to
a rise in intracellular Ca2+ resulting from influx through NMDARs; this form is
referred to as Ca2+-dependent desensitization (Legendre et al., 1993; Vyklický,
1993; Zorumski et al., 1989). The glycine-dependent form of desensitization seems
to underlie the allosteric coupling of the glutamate- and glycine-binding sites, so
that binding of glutamate decreases the affinity for glycine (Benveniste et al.,
1990; Mayer et al., 1989a). The third form of NMDAR desensitization is Ca2+-
and glycine-independent (Sather et al., 1992, 1990). Similar to the deactivation, all
forms of desensitization are subunit-dependent. The combination of agonist and
coagonist binding, opening and closing, transient Mg2+ block, desensitization, and
agonist/coagonist unbinding determine the characteristic time course of NMDA
EPSCs during a synaptic event.
1.3.6 Modulation of NMDA receptor function
The NMDAR channel function can be modulated by various endogenous and ex-
ogenous agents (McBain and Mayer, 1994). The main endogenous modulators are
Zn2+, protons, and polyamines (Dingledine et al., 1999).
Although the exact concentration of Zn2+ in the brain and especially within the
synaptic cleft is still controversial, it is clear that Zn2+ represents an important
modulator of NMDAR function (Smart et al., 2004) that is localized in synap-
tic vesicles at presynaptic glutamatergic terminals (Salazar et al., 2005). Zn2+ at
low micromolar concentrations was found to inhibit NMDAR responses (Peters et
al., 1987; Westbrook and Mayer, 1987). It turned out that this inhibition occurs
by a voltage-independent, allosteric (non competitive) mechanism and appears as
a decrease in the channel open probability (Christine and Choi, 1990; Legendre
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and Westbrook, 1990; Mayer et al., 1989b). At concentrations >20 µM, Zn2+
inhibits NMDARs by a voltage-dependent mechanism, probably by binding the
same residues inside the pore that are important for Mg2+ block (Christine and
Choi, 1990; Legendre and Westbrook, 1990; Mayer et al., 1989b; Paoletti et al.,
1997). However, strength and voltage dependence of Zn2+ block is weaker com-
pared to Mg2+ block, presumably because of an easier permeation of Zn2+ than
Mg2+ into the channel pore (Christine and Choi, 1990; Legendre and Westbrook,
1990; Mayer et al., 1989b; Paoletti et al., 1997). While the voltage-dependent
Zn2+ sensitivity is similar for all NMDAR subtypes, the voltage-independent Zn2+
sensitivity was shown to be subunit-dependent. NR2A-containing NMDARs have
a much higher Zn2+ sensitivity than all other NMDAR subtypes, being already
inhibited in the low nanomolar range, NR2B-containing receptors instead are only
inhibited in the low micromolar range (Paoletti et al., 1997; Traynelis et al., 1998).
The NR2A-specific Zn2+ inhibition is not complete, with 20-40% of the maximal
NMDAR current remaining (Chen et al., 1997; Paoletti et al., 1997). The NTD of
the NR2A and NR2B subunit form the Zn2+ binding site with different affinities.
In addition to the NR2 subunit dependence, Zn2+ inhibition is influenced by NR1
splice variants (Paoletti et al., 1997; Traynelis et al., 1998) and the NR1 subunit
might also participate in Zn2+ binding.
In the mammalian brain, the pH is highly dynamic and changes during synap-
tic transmission, glutamate receptor activation, glutamate uptake as well as un-
der pathological situations (Amato et al., 1994; Chesler, 1990; Chesler and Kaila,
1992). It influences glutamate receptor function, which becomes particularly ob-
vious by the inhibition of NMDARs by physiologically relevant concentrations of
protons: the IC50 value for proton inhibition corresponds to pH 7.3, so that the
receptor is tonically inhibited (∼50%) at physiological pH (Traynelis and Cull-
Candy, 1990). The inhibition occurs through reduction of the single-channel open-
ing frequency without affecting open time and conductance (McBain and Mayer,
1994). The acidification under pathological conditions causes stronger inhibition
of NMDARs and therefore minimizes their contribution to neurotoxicity (Kaku et
al., 1993; Tombaugh and Sapolsky, 1993). Like voltage-independent Zn2+ inhibi-
tion, NMDAR inhibition by protons is influenced by the NR2 subunit and NR1
splice variants. Residues influencing pH sensitivity are found on both NR1 and
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NR2 subunits (Gallagher et al., 1997; Kashiwagi et al., 1997). The physical loca-
tion of the proton sensor responsible for proton inhibition within the NMDAR is
still unknown, but mutagenesis studies of NMDAR subunits suggest that residues
within the linker regions connecting the NTD to the transmembrane pore-forming
elements contribute to proton-sensitive channel gating (Low et al., 2000; Zheng et
al., 2001). It has also been suggested that there is a tight coupling of the proton
sensor and gating (Kashiwagi et al., 1997; Traynelis et al., 1998).
Endogenous polyamines such as spermine or spermidine have complex effects
on NMDARs. At least three different effects of extracellular polyamines have
been described: voltage-dependent inhibition, glycine-dependent potentiation, and
voltage- and glycine-independent potentiation of NMDARs (Rock and Macdonald,
1995; Williams, 1997). The voltage-dependent inhibition involves similar residues
as Mg2+ and Zn2+ block inside the channel pore (Kashiwagi et al., 1997) and is
dependent on the NR2 subunit. Similar to Mg2+, it is due to fast-channel block,
but of lower affinity and therefore likely negligible under physiological conditions
(Williams, 1997). Other inhibitory effects may involve a decrease in the affinity
for glutamate (Williams, 1994). Both glycine-dependent and glycine-independent
polyamine potentiation of NMDAR function are influenced by the NR2 subunit.
Glycine-dependent potentiation occurs at NR2A- and NR2B-containing receptors
(Williams, 1994; Zhang et al., 1994) and is not influenced by NR1 splice vari-
ants (Durand et al., 1993). It involves an increase in channel opening frequency
and decrease of desensitization of NMDARs, probably reflecting relief of tonic
proton inhibition (Benveniste and Mayer, 1993; Lerma, 1992; Rock and Macdon-
ald, 1992; Traynelis et al., 1995). In contrast, glycine-independent potentiation
is described only for NR2B-containing receptors and is influenced by NR1 RNA
splicing (Durand et al., 1993; Williams, 1994; Zhang et al., 1994). This form of
polyamine potentiation involves an increase in the affinity of NMDARs for glycine
(Benveniste and Mayer, 1993; McGurk et al., 1990).
1.3.7 Pharmacology of NMDA receptor subtypes
Numerous NMDAR antagonists have been developed to study NMDAR functions,
but pharmacological tools discriminating between NMDAR subtypes remain lim-
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ited. Three major classes of NMDAR antagonists can be distinguished on the basis
of their mechanism of antagonism: (1) Competitive NMDAR antagonists act at the
agonist or coagonist binding domains, (2) NMDAR channel blockers block the pore
after channel activation, and (3) non-competitive allosteric NMDAR antagonists
act at extracellular domains (Fig. 3).
The first NMDAR antagonists were competitive antagonists acting on the glu-
tamate binding site of the NR2 subunit. One of the first compounds discovered
was (D)-2-amino-5-phosphonopentanoate (D-AP5; Davies et al., 1981), which is
still widely used because it displays strong preference for NMDARs over all other
iGluRs. Competitive antagonists (D-AP5, D-AP7, D-CPP) show some selectivity
between the different NR2 subunits (affinity ranking typically NR2A > NR2B >
NR2C > NR2D), but the affinity differences are smaller than 10-fold and conse-
quently do not allow selective inhibition of a particular receptor subtype (Feng et
al., 2005). A more recent competitive antagonist, the Novartis compound NVP-
AAM077, has enhanced selectivity for NR1/NR2A over NR1/NR2B receptors.
However, its selectivity has been overestimated, because the 100-fold difference in
affinity for NR1/NR2A over NR1/NR2B recombinant human receptors expressed
in oocytes (Auberson et al., 2002; Liu et al., 2004) turned out to be only 12-
fold for the respective recombinant rodent receptors (Berberich et al., 2005; Feng
et al., 2004; Weitlauf et al., 2005). In addition, it also antagonizes NR2C- and
NR2D-containing receptors (Feng et al., 2004).
The second class of antagonists inhibits NMDARs by occluding the ion channel
pore. These channel blockers are uncompetitive antagonists and require receptor
activation, i.e. channel opening, in order to bind within the channel pore. Channel
blockers like phencyclidine (PCP), ketamine, memantine, and amantadine discrim-
inate only poorly between NMDARs subtypes (Bresink et al., 1996; Yamakura
et al., 1993), and also the highly selective NMDAR channel blocker dizolcipine
(MK-801) which is more potent at inhibiting NR1/NR2A and NR1/NR2B recep-
tors than NR1/NR2C and NR1/NR2D receptors has a less than 10-fold difference
in affinity (Yamakura et al., 1993).
In addition to Zn2+ that is an endogenous subunit-specific allosteric NMDAR
modulator, synthetic organic inhibitors with subtype selectivity have been devel-
oped. Ifenprodil was discovered to display strong (>200-fold) selectivity for NR2B-
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Fig. 3: Potential ligand binding
sites at NMDARs. For clarity,
only one of the two NR1/NR2 het-
erodimers is shown. The NR2 LBD
binds glutamate, the NR1 LBD
binds the coagonist. White ar-
rows indicate binding sites for com-
petitive agonists and antagonists.
Thick orange arrows indicate sites
that bind allosteric modulators
(e.g. Zn2+ or ifenprodil and deriva-
tives), acting as non-competitive
antagonists. Pore blockers (e.g.
Mg2+ or MK-801) bind in the ion
channel pore (adapted and modified
from Paoletti and Neyton, 2007).
containing receptors (Williams, 1993). Because of the poor selectivity of ifenprodil
concerning other classes of receptors like e.g. alpha-adrenergic and serotoninergic
receptors, derivatives with higher selectivity have been developed. Such deriva-
tives like Ro25-6981 and CP-101,606 show even higher selectivity (up to 3000-fold
difference) for the NR2B-subunit compared to ifenprodil (Fischer et al., 1997; Mott
et al., 1998). Ifenprodil and derivatives are allosteric NMDAR inhibitors with se-
lectivity for the NR2B subunit (Williams, 1993) and inhibit NR2B-containing re-
ceptors by a non-competitive and voltage-independent mechanism. Ifenprodil and
derivatives bind to the NR2B-NTD (Gallagher et al., 1996; Perin-Dureau et al.,
2002) and inhibit the NMDAR by increasing the sensitivity of the receptor to neg-
ative modulation by protons, thus enhancing tonic inhibition at physiological pH
(Mott et al., 1998). Due to their subtype selectivity, ifenprodil and its derivatives
seem to be convenient tools to decipher NMDAR subtype-specific roles. However,
difficulties arising from the coexistence of di- and triheteromeric NR2B-containing
receptors as well as drug-specific properties have to be considered when relating
drug effects to specific NMDAR subtypes and will be described and discussed in
detail later.
Introduction 19
1.3.8 NMDA receptors and disease
Inappropriate activation of NMDARs has been implicated in the etiology of a range
of acute and chronic neurodegenerative disorders (e.g. hypoxic-ischaemic injury,
occuring after stroke or brain trauma, Parkinson, Huntington, Alzheimer, and
epilepsy). Excessive Ca2+ influx through NMDARs can cause excitotoxic neuronal
death, and thus, blockade of NMDARs was shown to be neuroprotective in animal
models of stroke and epilepsy (Lee et al., 1999), turning modulators of NMDAR
function into promising therapeutic targets for the treatment of many brain dis-
orders. However, the usefulness of non-selective NMDAR antagonists was limited
because of intolerable side effects (e.g. hallucinations, memory, and motor deficits),
partly arising by their action on normal synaptic transmission. Therefore, block-
ade of excessive NMDAR activity has to be achieved without interference with
physiological activity. The lack of discrimination between the different NMDAR
subtypes is considered as one explanation for the failures of the first-generation
NMDAR antagonists in clinical trials. Subunit-selective NMDAR antagonists have
an improved side effect profile compared to the broad-spectrum antagonists. Ifen-
prodil and derivatives are attractive for clinical use for two reasons: first, the
NR2B-directed antagonists are relatively well tolerated and second, they are max-
imally active at persistently activated NMDARs and at acidic pH (activity and pH
dependence; Kew et al., 1996; Mott et al., 1998), conditions that often occur in
pathological situations. Although NR2B-directed NMDAR antagonists show good
efficacy as neuroprotectants and/or analgesics in various animal models (Chizh
and Headley, 2005), none of them has yet completed clinical trials and developed
into an approved drug because of emerging side effects in recent clinical studies
(e.g. see Chaperon et al., 2003; Nicholson et al., 2007). In contrast, the low affin-
ity, broad-spectrum NMDAR channel blocker memantine has been approved for
the treatment of moderate to severe Alzheimer’s disease. Memantine is thought to
mediate its beneficial effects by normalizing aberrant, disease-associated NMDAR
activation without affecting physiological activity. Its exceptional clinical toler-
ance might be due to its low affinity binding to open channels and its relatively
fast unblocking kinetics (Johnson and Kotermanski, 2006; Lipton, 2006).
Hypofunction of NMDARs may be related to some human cognitive disorders,
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in particular schizophrenia. Non-selective NMDAR channel blockers like PCP or
ketamine disrupt memory function and cause a schizophrenia-like phenotype in
healthy humans (Tsai and Coyle, 2002). Reduced NMDAR expression or impaired
NMDAR function in transgenic mice leads to schizophrenia-related behaviours
(Ballard et al., 2002; Mohn et al., 1999). Thus, positive modulators might rep-
resent a strategy to enhance NMDAR function under pathological conditions of
receptor hypofunction, but should exclude the triggering of excitotoxicity through
receptor overactivation. To date, enhancing NMDAR function under pathologi-
cal conditions of NMDAR hypofunction is tried to be achieved by enhancing the
glycine site occupancy, and these studies have yielded encouraging preliminary
data (Javitt, 2008).
1.4 Hippocampus
An excellent framework to study NMDAR-related questions is the hippocam-
pus. The hippocampus plays important roles in long-term memory, in particular
episodic and semantic memory, and spatial navigation. It is a paired structure and
located bilaterally in the medial temporal lobe of the brain. The hippocampus be-
longs to the limbic system and has the shape of a curved tube. The hippocampal
subregions CA1 to CA3 and their neighbouring regions, the dentate gyrus, subicu-
lum and entorhinal cortex, are collectively termed the ‘hippocampal formation’.
Its functional organization has traditionally been described as trisynaptic circuit,
containing three major afferent pathways appearing as three excitatory synapses in
series (Fig. 4): (1) The medial and lateral perforant-path (MPP and LPP) arising
from the entorhinal cortex (EC) project to granule cells of the dentate gyrus (DG)
and to pyramidal cells in CA3, CA1, and subiculum (Sb). The perforant path is
considered to be the major input to the hippocampus. (2) The axons of DG gran-
ule cells, termed mossy fibers, innervate pyramidal cells in CA3. (3) Axons of the
CA3 pyramidal cells, termed Schaffer collaterals, project to CA1 pyramidal cells.
CA3 pyramidal cells can also form synapses with CA1 pyramidal cells from the
contralateral hippocampus. The principal output from the hippocampus is formed
by the pathway from CA1 to the subiculum and to the EC. Besides the EC input
the hippocampus receives further input from the medial septum, the brainstem,
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Fig. 4: The hippocampal network. The hippocampus forms a principally uni-
directional network, with input from the entorhinal cortex (EC) that projects to the
dentate gyrus (DG) and pyramidal cells via the perforant path (PP - split into lateral
and medial). The mossy fiber (MF) pathway connects the granule cells to the CA3 pyra-
midal cells. CA3 neurons send axons to CA1 pyramidal cells via the Schaffer collateral
pathway (SC), as well as to CA1 in the contralateral hippocampus via the associational
commissural pathway (AC). CA1 neurons send axons to the subiculum (Sb) and to the
EC. The main hippocampal output from CA1 and Sb goes to the lateral EC (LEC) and
medial EC (MEC) (adapted from Collingridge G., MRC laboratory, Bristol).
hypothalamus, thalamus, and amygdala.
The hippocampus is organized in three layers: the polymorphic layer (stratum
oriens), the pyramidal layer (stratum pyramidale), and the molecular layer (stra-
tum radiatum and stratum lacunosum moleculare).
1.5 Aim of the project
Diheteromeric NR1/NR2 receptors have been extensively studied in heterologous
systems and in cultured neurons, leading to the identification of NR2 subunit-
specific synthesis, trafficking, and degradation pathways (Yashiro and Philpot,
2008). In contrast, NR2 subunit-specific roles in the induction of synaptic plastic-
ity (Collingridge et al., 2004) or excitotoxicity (Liu et al., 2007; Martel et al.,
2009; von Engelhardt et al., 2007) remain inconclusive, especially in neuronal
preparations, which contain di- and triheteromeric NMDARs (Al-Hallaq et al.,
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2007; Brickley et al., 2003; Chazot et al., 1994; Kew et al., 1998; Luo et al., 1997;
Sheng et al., 1994; Tovar and Westbrook, 1999). Presence of two different NR2
subunits within triheteromeric NMDARs could lead to unique receptor properties
expanding the repertoire of diheteromeric NMDAR signaling. The difficulty to
isolate triheteromeric NMDARs leaves their abundance, properties, and function
ambiguous.
Expression of NR2A and NR2B in adult CA1 pyramidal cells leads to the for-
mation of NR1/NR2A, NR1/NR2B, and NR1/NR2A/NR2B receptors (Al-Hallaq
et al., 2007; Chazot et al., 1994; Kew et al., 1998; Luo et al., 1997; Sheng et al.,
1994). The aim of this study was to decipher the synaptic NMDAR composition
in CA1 neurons and to explore whether NR1/NR2A/NR2B receptors contribute
to synaptic transmission. In order to find a signature of NR1/NR2A/NR2B recep-
tors in CA3-to-CA1-synapses by whole-cell patch-clamp recordings, we analyzed
subtype-specific characteristics of diheteromeric NMDARs in acute slices of mice in
which either NR2A was constitutively ablated (NR2A−/−, Sakimura et al., 1995),
or NR2B was selectively removed from principal forebrain neurons (NR2B∆Fb, von
Engelhardt et al., 2008). These subtype-specific characteristics were compared to
characteristics found in age-matched wild-type mice (WT), which express trihete-
romeric NMDARs in addition to the two diheteromeric NMDAR subtypes. This
approach combined with the use of pharmacology in wild-type mice allowed us to
estimate the NR1/NR2A/NR2B receptor proportion of the total NMDAR popu-
lation in the hippocampus and may help to identify NMDAR subtypes in other
brain regions.
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2 Results
2.1 Sensitivity of NMDA EPSCs to extracellular
Mg2+
2.1.1 Mg2+ sensitivity of NMDA EPSC amplitudes
Agonist evoked currents mediated by recombinant NR1/NR2A receptors deacti-
vate 3-4-fold faster than those mediated by recombinant NR1/NR2B receptors
(Dingledine et al., 1999), while their sensitivity to extracellular Mg2+ is simi-
lar (Kuner and Schoepfer, 1996; Monyer et al., 1994). We performed whole-cell
patch-clamp recordings in order to investigate the sensitivity to Mg2+ for differ-
ent synaptic NMDAR subtypes in acute hippocampal slices. We stimulated the
Schaffer collaterals and compared the amplitudes of NMDA EPSCs recorded at
−40 and +40 mV in hippocampal CA1 neurons before and after washout of ex-
ternal Mg2+. Diheteromeric NR1/NR2B receptors were investigated in NR2A−/−
mice (Sakimura et al., 1995), and diheteromeric NR1/NR2A receptors in condi-
tional NR2B∆Fb mice (von Engelhardt et al., 2008) to avoid perinatal lethality
from complete NR2B knockout (Kutsuwada et al., 1996). Di- and triheteromeric
NMDARs were investigated in age-matched wild-type mice (WT).
In NR2B∆Fb mice, NR2B is progressively removed over the first three postna-
tal months from principal forebrain neurons, including CA1 pyramidal cells. In
36 of 79 CA1 neurons recorded in P44 NR2B∆Fb mice, NMDA EPSCs had sig-
nificantly shorter decay times than in wild-type mice and were unaffected by the
NR2B-directed NMDAR antagonist CP-101,606 (10 µM; not shown), indicating
the absence of NR2B subunits; thus NMDA EPSCs were mediated exclusively by
NR1/NR2A receptors in these cells. A subset of the 36 cells was used for this
project (Table 1).
Each mutant mouse line was compared to wild type at the respective age
(NR2A−/− mice at P28; see Fig. 5A and 6A, B left panels, and NR2B∆Fb mice at
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P44; see Fig. 5B and 6A, B right panels). For all three genotypes, Mg2+ washout
similarly increased the amplitudes of NMDA EPSCs at −40 mV 3-4-fold (P28 and
P44, p > 0.05), whereas changes of amplitudes at +40 mV were negligible and not
different within each age group (P28 and P44, p > 0.05) (Fig. 5 A, B).
Thus, the sensitivity to Mg2+ block is comparable for synaptic NMDARs of the
three genotypes.
Table 1: Deactivation kinetics for NMDA EPSCs (ms) recorded in CA1 neu-
rons of wild-type, NR2A−/− and NR2B∆Fb mice at −40 and +40 mV in pres-
ence and absence of Mg2+ at the indicated ages. For each condition, # indi-
cates significance following Mg2+ washout and † indicates significance between −40 and
+40 mV. Compared with both NR2 mutants, NMDA EPSC decay time in wild type was
intermediate and distinct (p < 0.0001). From P5 to P28/P44, decay time accelerated in
wild type in presence (p < 0.0001) and absence of Mg2+ (p < 0.05). Number of cells is
indicated in parenthesis.
membrane 1 mM Mg2+genotype
potential P5 P28 P44
−40 mV 83±4.15 (17) 53±2.49 (21) 55±2.11 (16)WT
+40 mV 229±17.12† (17) 123±5.32† (21) 113±2.70† (16)
−40 mV 146±13.87 (18) 233±18.60 (9)NR2A−/−
+40 mV 303±23.73† (18) 307±16.18† (9)
−40 mV 25±1.20 (9)NR2B∆Fb
+40 mV 52±2.94† (9)
membrane 0 mM Mg2+genotype
potential P5 P28 P44
−40 mV 128±5.02# (14) 100±8.49# (21) 94±7.27# (16)WT
+40 mV 218±18.77† (12) 161±14.63#,†(21) 131±6.23#,† (16)
−40 mV 237±22.48# (14) 306±16.64# (9)NR2A−/−
+40 mV 374±48.51† (14) 302±18.32 (9)
−40 mV 34±3.24# (9)NR2B∆Fb
+40 mV 57±3.54† (9)
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Fig. 5: Mg2+ sensitivity of amplitudes of NMDA EPSCs in wild-type,
NR2A−/− and NR2B∆Fb mice. A, Left, representative averaged current traces be-
fore (black) and after (grey) Mg2+ washout for P28 wild-type and P28 NR2A−/− mice.
Blue traces at −40 mV represent black traces scaled to the amplitude of grey traces.
Bars show peak ratios, illustrating effects of Mg2+ washout on amplitudes of pharma-
cologically isolated (NBQX, 10 µM) NMDA EPSCs recorded in CA1 cells at −40 mV
(downwards) and +40 mV (upwards). The basis of the bars at 0 is marked by a white
line. At −40 mV, NMDA EPSCs increased 3.60 ± 0.33 -fold in P28 wild-type (n = 21,
#p < 0.0001) and 3.16 ± 0.48 -fold in P28 NR2A−/− mice (n = 9, #p < 0.001). At
+40 mV, NMDA EPSCs remained unchanged (WT, 0.89 ± 0.05, n = 21, p = 0.0497;
NR2A−/−, 0.86 ± 0.07, n = 9, p = 0.0804). B, same asA, but for P44 wild-type (n = 11)
and P44 NR2B∆Fb mice (n = 7) at −40 mV (WT, 4.10 ± 0.29, #p < 0.0001; NR2B∆Fb,
4.12 ± 0.51, #p < 0.001) and at +40 mV (WT, 1.12 ± 0.11, p = 0.1480; NR2B∆Fb,
1.07 ± 0.09, p = 0.3433).
2.1.2 Mg2+ sensitivity of NMDA EPSC decay time
Consistent with recombinant diheteromeric NMDARs (Cull-Candy and Leszkiewicz,
2004; Monyer et al., 1994; Vicini et al., 1998), NR1/NR2B receptor-mediated
NMDA EPSCs at CA1 synapses of NR2A−/− mice decayed significantly slower
than NR1/NR2A receptor-mediated NMDA EPSCs in NR2B∆Fb mice (about
9-fold slower at −40 mV and about 6-fold slower at +40 mV; Fig. 6A, Table 1).
This difference was observed in presence of Mg2+ as well as following washout
of Mg2+, which prolonged the decay time constants of NMDA EPSCs, consistent
with previous findings (Konnerth et al., 1990). In wild-type mice, the decay time
of NMDA EPSCs was distinct (p < 0.0001) and intermediate when compared
with that in both NR2 mutant mouse lines. This intermediate decay phenotype in
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wild type could be due to the coexistence of NR1/NR2A and NR1/NR2B recep-
tors in hippocampal synapses and does not necessarily identify the contribution of
NR1/NR2A/NR2B receptors.
Fig. 6: Mg2+ sensitivity of deactivation kinetics of NMDA EPSCs in wild-type,
NR2A−/− and NR2B∆Fb mice. See Fig. 5 for representative current traces. A, Aver-
aged decay time constants (Tauweighted) for P28 wild-type (n = 21) and NR2A−/− (n = 9)
mice (left), and for P44 wild-type (n = 16) and NR2B∆Fb (n = 9) mice (right), in pres-
ence (black bars) and absence (grey bars) of Mg2+ at −40 mV (downwards) and +40 mV
(upwards). Compared to wild type, NMDA EPSCs were slower in NR2A−/− mice and
faster in NR2B∆Fb mice (p < 0.0001, respectively). At −40 mV, Mg2+ washout slowed
down the decay time in all three genotypes, but at +40 mV only in wild type. For statisti-
cal comparison, see B. B, Changes of deactivation kinetics in % following Mg2+ washout
for P28 wild-type (n = 21) and NR2A−/− (n = 9) mice (left) as well as for P44 wild-type
(n = 16) and NR2B∆Fb (n = 9) mice (right). At −40 mV, decay changes were more
pronounced in wild-type than in the two NR2 mutants (WT P28/P44, 88.24 ± 11.75%
/ 71.11 ± 12.99%, #p < 0.0001 / #p < 0.0001; NR2A−/−, 37.47 ± 13.66%, #p < 0.01;
NR2B∆Fb, 36.50 ± 11.73%, #p < 0.05). At +40 mV, decay changes occured exclusively
in wild type (WT P28/P44, 28.29 ± 8.55% / 16.34 ± 6.73%, #p < 0.01 / #p = 0.0322;
NR2A−/−, 0.60 ± 6.01%, p = 0.7740; NR2B∆Fb, 11.01 ± 5.48%, p = 0.1043).
Notably, the NMDA EPSC decay time slowdown due to Mg2+ washout is more
pronounced at negative than at positive membrane potentials in dentate gryrus
granule cells (Konnerth et al., 1990). We also found this difference for NMDA
EPSCs in CA1 synapses for all three genotypes, but to different extents. The
slowdown of the NMDA EPSC decay time was more pronounced for wild-type
than for both NR2 mutants at −40 mV (Fig. 6B). At +40 mV, the decay time of
NMDA EPSCs slowed down only for wild-type mice, but remained unchanged for
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NR2A−/− and NR2B∆Fb mice (Fig. 6; Table 1). Thus, removal of Mg2+ changed
the deactivation kinetics of NMDA EPSCs at negative and positive potentials in
wild type, but exclusively at negative potentials and to a lesser extent in both
NR2 mutants. To our knowledge, this observation provides the first evidence that
a population of NMDARs distinct from diheteromeric NR1/NR2A and NR1/NR2B
receptors contributes to NMDA EPSCs in wild-type hippocampal slices.
2.2 Voltage dependence of NMDA EPSC decay
time in adult wild-type mice and
gene-targeted mouse lines
2.2.1 Voltage dependence of NMDA EPSC decay time in
the presence of 1 mM Mg2+
In wild-type mice, Mg2+ confers voltage dependence to the decay time of NMDA
EPSCs, with slower kinetics at depolarized potentials (Hestrin, 1992). To esti-
mate the voltage dependence of decay for NMDA EPSCs recorded in wild-type,
NR2A−/− and NR2B∆Fb mice, we calculated the −40 mV/+40 mV ratio of the
decay time constants. A small ratio reflects marked voltage dependence of decay.
Fig. 7 shows the ratios for P28 only, because NMDA EPSCs were comparable in
wild type at P28 and P44 (Figs. 5 and 6). In the presence of Mg2+, NMDA EPSCs
in NR2A−/− mice displayed a significantly reduced voltage dependence compared
to wild-type and NR2B∆Fb mice (Fig. 7). Thus, Mg2+-dependent voltage depen-
dence was different for NR1/NR2A and NR1/NR2B receptors.
2.2.2 Voltage dependence of NMDA EPSC decay time in
the absence of Mg2+
Even in the absence of Mg2+, NMDA EPSCs show voltage dependence and de-
cay slower at depolarized than at more negative membrane potentials (Kirson and
Yaari, 1996; Konnerth et al., 1990). As Mg2+ confers voltage dependence to the
decay time of NMDA EPSCs, washout of Mg2+ increased the −40 mV/+40 mV
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Fig. 7: Mg2+-dependent voltage dependence of NMDA EPSC decay time in
adult wild-type, NR2A−/− and NR2B∆Fb mice. Left panels, averaged represen-
tative current traces show NMDA EPSCs in the presence of 1 mM Mg2+ at +40 mV in
black and NMDA EPSCs at −40 mV scaled to EPSCs at +40 mV in red. Right panel, the
bar diagram shows the ratio of Tauweighted −40 / Tauweighted +40 mV in the presence of
1 mM Mg2+. In all three genotypes, decay time was slower at +40 mV than at −40 mV
(WT, 0.43 ± 0.02, n = 21, †p < 0.0001; NR2A−/−, 0.76 ± 0.05, n = 9, †p < 0.05;
NR2B∆Fb, 0.49 ± 0.03, n = 9, †p < 0.0001). Voltage dependence of decay was reduced
in NR2A−/− mice compared to wild-type and NR2B∆Fb mice (ANOVA, ∗p < 0.01) and
was similar in wild-type and NR2B∆Fb mice (ANOVA, p >0.05).
ratio of the decay time constants as expected. In the presence of Mg2+, NMDA
EPSCs in NR2A−/− mice displayed a significantly reduced voltage dependence
compared to wild-type and NR2B∆Fb mice (Fig. 7). This genotypic difference
was also observed in the absence of Mg2+. NMDA EPSCs still decayed slower at
positive than at negative potentials in wild-type and NR2B∆Fb mice, whereas the
decay time of NMDA EPSCs in NR2A−/− mice was similar at −40 and +40 mV
(Fig. 8). This demonstrates that voltage dependence of NMDA EPSCs was dif-
ferent for pure synaptic diheteromeric NMDARs in the presence as well as in the
absence of Mg2+.
Voltage dependence of NMDA EPSC decay in presence and absence of Mg2+
was similar for NR1/NR2A receptors in NR2B∆Fb mice and for the NMDARs in
wild-type mice. Therefore, the absence of the distinct voltage dependence of decay
for synaptic NR1/NR2B receptors in wild type let us conclude that NR1/NR2B re-
ceptors contribute to a minor extent to NMDA EPSCs in adult wild-type mice. In
addition, the presence of a mixture of pure NR1/NR2A and NR1/NR2B receptors
in wild-type synapses can be excluded, since we did not observe an intermediate
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value for the voltage dependence of decay. In contrast, an intermediate value for
NMDA EPSC decay time was observed in wild type compared to the two NR2 mu-
tants (see chapter 2.1.2). Thus, synaptic triheteromeric NR1/NR2A/NR2B recep-
tors mediate NMDA EPSCs with slower deactivation kinetics than diheteromeric
NR1/NR2A receptors, but NR1/NR2A/NR2B and NR1/NR2A receptors display
similar voltage dependence of decay.
In summary, our analysis of voltage dependence and decay time of NMDA
EPSCs in three genotypes strongly suggests that NMDA EPSCs in adult CA3-
to-CA1 synapses are mainly mediated by NR1/NR2A and NR1/NR2A/NR2B re-
ceptors.
Fig. 8: Mg2+-independent voltage dependence of NMDA EPSC decay time
in adult wild-type, NR2A−/− and NR2B∆Fb mice. Left panels, averaged repre-
sentative current traces show NMDA EPSCs in the absence of Mg2+ at +40 mV in grey
and NMDA EPSCs at −40 mV scaled to EPSCs at +40 mV in red. Right panel, the
bar diagram shows the ratio of Tauweighted −40 / Tauweighted +40 mV in the absence
of Mg2+. For wild-type and NR2B∆Fb mice, decay time was slower at +40 mV than
at −40 mV, but similar at −40 mV and +40 mV for NR2A−/− mice (WT, 0.66 ± 0.04,
n = 21, †p < 0.001; NR2A−/−, 1.02 ± 0.03, n = 9, p = 0.94; NR2B∆Fb, 0.60 ± 0.05,
n = 9, †p < 0.0001). The Mg2+-independent voltage dependence of decay in wild-type
and NR2B∆Fb mice was different from NR2A−/− mice (ANOVA, ∗p < 0.01).
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2.3 Examination of the NMDA receptor
composition in neonatal CA3-to-CA1
synapses
2.3.1 Voltage dependence of NMDA EPSC decay time in
neonatal wild-type and NR2A−/− mice
Our experiments revealed a distinct voltage dependence of decay for NMDA EPSCs
mediated via NR1/NR2B receptors in P28 NR2A−/− mice, that was not observed
in CA1 neurons of adult wild-type mice (Figs. 7, 8). As NR2B expression is
high at early postnatal stages when NR2A expression is still low (Monyer et al.,
1994; Watanabe et al., 1993), we expected to find characteristics of NMDA EPSCs
in neonatal wild-type similar to those in adult NR2A−/− mice (Figs. 7, 8). In-
deed, the presence of NR1/NR2B receptors in P5 wild-type mice was suggested
by a slowdown of NMDA EPSC decay time only at −40 mV caused by the Mg2+
washout similar to that observed for NR1/NR2B receptors in P28 NR2A−/− mice
(P5 WT, −40 mV, 53.01 ± 10.53%, n = 14; p < 0.0001; +40 mV, 0.10 ± 10.95%,
n = 12; p > 0.05; P28 NR2A−/−, −40 mV, 37.47 ± 13.66%, n = 9, p < 0.01;
+40 mV, 0.60 ± 6.01% n = 9; p > 0.05; Fig. 6B and Table 1). Similarly, the
voltage dependence of NMDA EPSC decay should be less pronounced in neonatal
than adult wild-type mice. However, voltage dependence of NMDA EPSC decay
in neonatal wild-type mice was not different from that in adult wild-type mice
(1 mM and 0 mM Mg2+, p > 0.05; Figs. 7 and 8 vs. Fig. 9), and for both develop-
mental stages, it was more pronounced than in adult NR2A−/− mice (1 mM Mg2+,
p < 0.0001; 0 mM Mg2+, p < 0.01; Figs. 7 and 8 vs. Fig. 9). These observations
indicate that voltage dependence of NMDA EPSC deactivation remains constant
over development in wild-type mice, which may be accomplished by NR2 subunits
in addition to NR2B.
To check whether NR2A-containing NMDARs could be present in neonatal
wild-type synapses and contribute to the observed voltage dependence of NMDA
EPSCs, we investigated NMDA EPSCs in neonatal NR2A−/− mice. Surprisingly,
compared to adult NR2A−/− mice, NMDA EPSCs recorded in neonatal exhibited
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stronger voltage dependence of NMDA EPSC decay time in presence and absence
of Mg2+ (p < 0.001 for 1 and 0 mM Mg2+; Figs. 7 and 8 vs. Fig. 9). Furthermore,
the voltage dependence of NMDA EPSC deactivation recorded in neonatal wild-
type and neonatal NR2A−/− mice was comparable (1 mM and 0 Mg2+, p > 0.05;
Fig. 9). Thus, early NR2A expression in hippocampal synapses is not the rea-
son for the stronger voltage dependence of NMDA EPSC decay time in neonatal
wild-type compared with adult NR2A−/− mice.
Fig. 9: Voltage dependence of NMDA EPSC deactivation kinetics in
neonatal wild-type and NR2A−/− mice. Averaged representative current traces
show NMDA EPSCs at +40 mV in black (A, normal Ringer solution containing
1 mM Mg2+) and in grey (B, Mg2+-free Ringer solution), and NMDA EPSCs at
−40 mV scaled to EPSCs at +40 mV in red. A, The bar diagram shows the ratio
Tauweighted −40 / Tauweighted +40 mV in presence of 1 mM Mg2+. For wild-type and
NR2A−/− mice, decay time was slower at +40 mV than at −40 mV and not different from
each other (p = 0.1799; WT, 0.41 ± 0.05, n = 17, †p < 0.0001; NR2A−/−, 0.50 ± 0.05,
n = 18, †p < 0.0001). B, same as A, but in the absence of Mg2+. Neonatal wild-
type and NR2A−/− mice showed similar Mg2+-independent voltage dependence of decay
(p = 0.7065; WT, 0.65 ± 0.09, n = 12, †p < 0.0001; NR2A−/−, 0.69 ± 0.06, n = 14,
†p < 0.01).
2.3.2 Effect of CP-101,606 on NMDA EPSCs in neonatal
and adult NR2A−/− mice
Instead of NR2A expression, the stronger voltage dependence of NMDA EPSC de-
cay time in neonatal versus adult NR2A−/− mice might arise from NR2D expres-
sion in young hippocampal synapses (Monyer et al., 1994). Because antagonists for
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NR1/NR2D receptors have poor subtype selectivity (Feng et al., 2004; Paoletti and
Neyton, 2007), we compared the effect of CP-101,606 (10 µM), an NR2B-directed
NMDAR antagonist, in neonatal and adult NR2A−/− mice. If NR2D was present
additionally to NR2B in neonatal CA3-to-CA1 synapses of NR2A−/− mice and de-
creases over development, the reduction of NMDA EPSCs by CP-101,606 should
be smaller in neonatal than in adult NR2A−/− mice. However, NMDA EPSCs
were reduced to similar extents in neonatal and adult NR2A−/− mice (Fig. 10),
arguing against the presence of NR1/NR2D receptors in synapses of neonatal CA1
pyramidal cells.
In summary, the voltage dependence of NMDA EPSC decay time in neonatal
wild-type synapses cannot be caused by the presence of NR2A or by NR1/NR2D
receptors, but rather by the presence of NR1/NR2B receptors displaying different
voltage dependence of deactivation over development.
Fig. 10: Effect of CP-101,606 on
NMDA EPSCs in neonatal and
adult NR2A−/− mice. NMDA
EPSCs were similarly reduced in neona-
tal and adult NR2A−/− mice (reduc-
tions in 0 mM Mg2+ and at −40 mV:
P5, 83.30 ± 2.53%, n = 4; P28,
80.33 ± 3.83%, n = 7; p > 0.05, and
at +40 mV: P5, 80.05 ± 2.62%, n = 4;
P28, 75.13 ± 4.53% n = 7; p > 0.05).
2.4 Effects of NR2B-directed NMDA receptor
antagonists on NMDA EPSCs during
postnatal development
2.4.1 Effects of CP-101,606
Next, we combined the characterization of the NMDAR composition in wild-type
synapses by subtype-specific kinetic properties deduced from NR2A and NR2B
mutant mice (Figs. 6, 7, 8) with a pharmacological approach. The NR2B-directed
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NMDAR antagonist CP-101,606 (10 µM) reduced NMDA EPSCs in the absence
of Mg2+ in neonatal wild-type mice by about 65%, and at P28 by about 50%
(Fig. 11A). Given that NR1/NR2B receptors appear to be a minor population in
adult hippocampal synapses (Figs. 5-9), the 50% reduction by CP101-606 at P28
must result from antagonism of NR1/NR2A/NR2B rather than NR1/NR2B recep-
tors. NR1/NR2A/NR2B receptors likely contribute to NMDA EPSCs more than
50%, because CP-101,606 (10 µM) antagonizes recombinant NR1/NR2B receptors
in 0 mM Mg2+ only up to 80-90% (Mott et al., 1998; Williams, 1993).
Fig. 11: Effects of CP-101,606 on NMDA EPSCs in neonatal versus adult
wild-type mice. Averaged representative current traces show NMDA EPSCs at −40
and +40 mV in absence (A, grey) and presence (B, black) of Mg2+ before and after
(green) perfusion of CP-101,606 (10 µM; 20 min). A, Reduction of NMDA EPSCs
recorded at −40 and +40 mV by CP-101,606 in Mg2+-free Ringer solution for P5 and
P28 wild-type mice (P5, 68.18 ± 2.89% (n = 6) at −40 mV; 61.53 ± 2.80% (n = 6)
at +40 mV; P28, 54.98 ± 4.08% (n = 9) at −40 mV and 52.0 ± 3.44% (n = 9) at
+40 mV). From P5 to P28, the effect of CP-101,606 was significantly reduced at −40 mV
(∗p < 0.05), but not at +40 mV (p = 0.0700). B, same as A, but in presence of 1 mM
Mg2+ (P5, 57.47 ± 5.19% (n = 7) at −40 mV and 46.01 ± 5.35% (n = 7) at +40 mV;
P28, 14.47 ± 4.45% (n = 7) at −40 mV and 17.0 ± 5.39% (n = 7) at +40 mV). The
effect of CP-101,606 was significantly reduced from P5 to P28 (−40 mV, ∗p < 0.0001;
+40 mV, ∗p < 0.01).
Previous studies demonstrated a developmental decrease in the sensitivity of
NR2B-directed NMDAR antagonists in various brain regions (Barth and Malenka,
2001; Bellone and Nicoll, 2007; Brothwell et al., 2008; de Marchena et al., 2008;
Lopez de Armentia and Sah, 2003), explained by a postnatal increase in NR2A
expression (Monyer et al., 1994; Sans et al., 2000; Sheng et al., 1994). Under our
experimental conditions in 0 mM Mg2+, the sensitivity of CP-101,606 was only
moderately reduced from P5 to P28 at −40 mV and did not change at +40 mV
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(Fig. 11A). When repeating this experiment in presence of the physiological Mg2+
concentration (1 mM), sensitivity of CP-101,606 was significantly reduced from
P5 to P28 (Fig. 11B), indicating that the recording conditions can influence the
sensitivity of CP-101,606.
2.4.2 Effects of ifenprodil
In addition to CP-101,606, we also used ifenprodil (3 µM), another NR2B-directed
NMDAR antagonist. Consistent with CP-101,606, the sensitivity of ifenprodil was
not reduced from P5 to P28 in the absence, but in the presence of Mg2+ (Fig. 12A,
B). At P28 and in presence of Mg2+, NMDA EPSCs were not only less sensitive to
ifenprodil compared to P5, but even increased (Fig. 12B; see also Kew et al., 1996).
The currents were completely blocked by the NMDAR antagonist D-APV (50 µM;
Fig. 12C), showing that the increased NMDA EPSCs after ifenprodil application
were mediated by NMDARs.
In summary, presence or absence of Mg2+ influenced the sensitivity of CP-101,606
and ifenprodil. Notably, the strong peak reduction of NMDA EPSCs in absence
of Mg2+ at P28 indicates that NR2B-containing NMDARs remain present in hip-
pocampal synapses throughout postnatal development, reflecting a successive re-
placement of NR1/NR2B receptors by NR1/NR2A/NR2B receptors. Interestingly,
even in cultured neurons, NR1/NR2A/NR2B receptors appear to be specifically
targeted to, and incorporated into, nascent synapses (Tovar and Westbrook, 1999).
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Fig. 12: Effects of ifenprodil on NMDA EPSCs in neonatal versus adult wild-
type mice. Averaged representative current traces show NMDA EPSCs at −40 and
+40 mV in absence (A, grey) and presence (B, black) of Mg2+ before and after (green)
perfusion of ifenprodil (3 µM; 20 min). A, Reduction of NMDA EPSCs by ifenprodil in
Mg2+-free Ringer solution for wild-type mice (P5, 35.74 ± 9.25% (n = 6) at −40 mV
and 29.94 ± 5.70% (n = 6) at +40 mV; P28, 40.03 ± 2.66% (n = 7) at −40 mV and
39.29 ± 7.52% (n = 7) at +40 mV). NMDA EPSCs were similarly reduced by ifenprodil
in neonatal and adult wild-type mice (−40 mV, p = 0.6752; +40 mV, p = 0.3488). B,
same as A, but in presence of 1 mM Mg2+ (P5, 50.70 ± 6.80% (n = 9) at −40 mV and
52.93% (n = 7) at +40 mV; P28, -38.86 ± 10.14% (n = 7) at −40 mV and -18.61 ± 6.69%
(n = 7) at +40 mV). The effect of ifenprodil was significantly reduced from P5 to P28
(p < 0.0001). C, Time course of NMDA EPSC amplitudes recorded in 1 mM Mg2+ at
+40 mV (open circles) and −40 mV (filled circles). NMDA EPSCs increased in the pres-
ence of ifenprodil (3 µM) and were subsequently blocked by D-APV (50 µM). Presence
of antagonists is indicated by bars.
2.5 Effects of CP-101,606 on NMDA EPSCs in
adult NR2A−/− mice
Recording conditions (absence versus presence of Mg2+) influenced the sensitivity
of CP-101,606 (Fig. 11). At P5, NMDA EPSCs showed a trend to be less inhibited
in 1 than in 0 mM extracellular Mg2+ (−40 mV, p > 0.05; +40 mV, p = 0.05),
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whereas at P28, NMDA EPSCs were more reduced in the absence than the presence
of Mg2+ (−40 mV, p < 0.0001; +40 mV; p < 0.001). Thus, the extent of influence
of Mg2+ on CP-101,606 sensitivity may depend on the presence of different NR2B-
containing NMDARs at P5 versus P28.
To investigate the influence of Mg2+ on the sensitivity of CP-101,606 inde-
pendent of NR1/NR2A/NR2B receptors, we examined the effect of CP-101,606
on NMDA EPSCs in CA1 cells of adult NR2A−/− mice, which contain only
NR1/NR2B receptors. In the absence of Mg2+, NMDA EPSCs were reduced by
about 80% (Fig. 13A), which is comparable to the maximal antagonism of recom-
binant NR1/NR2B receptors (80-90%; Mott et al., 1998; Williams, 1993). In the
presence of Mg2+, the effect of CP-101,606 was significantly reduced (−40 mV,
p < 0.001; +40 mV, p < 0.01; Fig. 13B), indicating that the sensitivity of
CP-101,606 is enhanced in the absence of Mg2+. As the reduction of the CP-effect
by Mg2+ is more pronounced for NMDARs in P28 wild-type than for NR1/NR2B
receptors in NR2A−/− mice (Fig. 11 vs. Fig. 13), the absence of Mg2+ seems to
strengthen the antagonism by CP-101,606 even more for triheteromeric NMDARs.
Thus, antagonism is reduced by presence of NR2A (Brimecombe et al., 1997; Hat-
ton and Paoletti, 2005; Tovar and Westbrook, 1999) and also by the presence of
Mg2+, as shown in Figs. 11 and 12.
Fig. 13: Effects of CP-101,606 on NMDA EPSCs in adult NR2A−/− mice.
Averaged representative current traces show NMDA EPSCs at −40 and +40 mV in
absence (A, grey) and presence (B, black) of Mg2+ before and after (green) perfusion
of CP-101,606 (10 µM). A, In Mg2+-free Ringer solution, CP-101,606 reduced NMDA
EPSCs at −40 mV by 80.33 ± 3.83% (n = 7) and +40 mV by 75.13 ± 4.53% (n = 7). B,
In the presence of 1 mM Mg2+, reduction of NMDA EPSCs by CP-101,606 was reduced
compared to Mg2+-free conditions (−40 mV, p < 0.001; +40 mV, p < 0.01; reduction at
−40 mV, 49.90 ± 5.41%, n = 7; +40 mV, 39.71 ± 7.86%, n = 7).
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3 Discussion
Key to this study was the analysis of the voltage dependence of NMDA EPSC decay
time in combination with the use of NR2B-directed NMDAR antagonists in acute
hippocampal slices of wild-type and two lines of gene-targeted mice, NR2A−/−
and NR2B∆Fb mice. The disruption of the NR2A subunit in NR2A−/− is reported
to have no effect on the mRNA expression of the remaining NMDAR subunits.
In addition, in NR2B∆Fb mice, no compensatory increase in NR2A expression
was observed, suggesting that no compensation of NMDAR subunit expression
occurred in the two gene-targeted mouse lines (Sakimura et al., 1995; von En-
gelhardt et al., 2008). Our results ascertain the presence of NR2B-containing
NMDARs in CA3-to-CA1 synapses throughout development and identify trihete-
romeric NR1/NR2A/NR2B receptors as a prominent NMDAR population (>50%)
in CA1 synapses of adult wild-type mice (P28/P44).
3.1 NMDA receptor composition of hippocampal
synapses
Triheteromeric NMDARs form without doubt (Al-Hallaq et al., 2007; Brickley
et al., 2003; Chazot et al., 1994; Kew et al., 1998; Luo et al., 1997; Sheng et
al., 1994; Tovar and Westbrook, 1999), but testing their relative abundance is
delicate. Biochemical approaches analyzing membrane fractions yielded differ-
ent amounts of triheteromeric NMDARs even within the same brain structure
(Al-Hallaq et al., 2007; Chazot et al., 1994; Kew et al., 1998; Luo et al., 1997;
Sheng et al., 1994). To identify different NMDAR subtypes within distinct cir-
cuits, e.g. at CA3-to-CA1 synapses, electrophysiologists usually test the sensi-
tivity of NMDA EPSCs to NMDAR antagonists, which were primarily charac-
terized for recombinant diheteromeric NMDARs. This approach allows conclu-
sions regarding NR2B-containing (NR2B-type) NMDARs but does not permit a
rigorous distinction between di- and triheteromeric NMDARs. During the first
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postnatal week, NMDA EPSCs in CA1 neurons are highly sensitive to NR2B-
directed NMDAR antagonists (our study; Bellone and Nicoll, 2007; Brothwell et
al., 2008; de Marchena et al., 2008; Lopez de Armentia and Sah, 2003). Here, in
adult wild-type mice (P28/P44), CP-101,606 reduced NMDA EPSCs about 50%
in the absence of Mg2+. Consistently, in mice older than five weeks, ifenprodil
reduced NMDA EPSCs by around 40% (Kirson and Yaari, 1996). Thus, exper-
iments with two different NR2B-specific antagonists support the hypothesis that
NR2B-containing NMDARs remain present in hippocampal synapses throughout
development. This is consistent with immunogold labeling of postsynaptic den-
sities (Köhr et al., 2003) and with our analysis of the NMDA EPSC decay time
in the three genotypes, showing that the decay time of NMDA EPSCs in adult
wild-type mice was 2-fold slower than the respective decay time for NR1/NR2A
receptors in NR2B∆Fb mice. However, synaptic NR1/NR2B receptors deactivate
6-9-fold slower than synaptic NR1/NR2A receptors. This argues against a 50%
contribution of NR1/NR2B receptors to NMDA EPSCs in wild type, because the
NMDA EPSC decay time is not halfway of that of the diheteromeric NMDARs.
Indeed, our demonstration that the voltage dependence of NMDA EPSC decay is
distinct for NR1/NR2B and NR1/NR2A receptors argues for a definite presence
of NR1/NR2A/NR2B receptors in adult synapses. If NR1/NR2B receptors were
to predominate in adult wild-type hippocampal synapses, their distinct voltage
dependence of decay would have caused a higher −40/+40 mV ratio of decay time
constants than the one we observed. In fact, the voltage dependence of decay
is identical in adult wild-type and NR2B∆Fb mice. Consequently, the NR2B-
containing receptors in adult wild-type mice represent mainly NR1/NR2A/NR2B
receptors. These synaptic triheteromeric NR1/NR2A/NR2B receptors mediate
NMDA EPSCs with slower deactivation kinetics than diheteromeric NR1/NR2A
receptors but display the NR1/NR2A-like voltage dependence of decay. Therefore,
in NR1/NR2A/NR2B receptors, the presence of NR2B likely slows the deactiva-
tion but the presence of NR2A confers the voltage dependence of decay. This
combination indicates a new property of NMDARs that cannot be explained by a
mixture of diheteromeric NR1/NR2A and NR1/NR2B receptors.
Outside synapses, NR1/NR2B receptors may exist and explain the finding of
a recent quantitative biochemical study, showing that NR1/NR2A, NR1/NR2B
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and NR1/NR2A/NR2B receptors each constitute approximately one-third of the
total NMDAR population at P7, P42, and 6 months (Al-Hallaq et al., 2007). On
the other hand, constant proportions of the three NMDAR subtypes throughout
development in the whole hippocampus are not in agreement with the increasing
NR2A/NR2B ratio during development (Monyer et al., 1994; Watanabe et al.,
1993). Indeed, the change in the synaptic NMDAR content during development
due to increased NR2A contribution is indicated by two facts: (1) the decay time
constant of NMDA EPSCs decreases during development, as seen in this and
previous studies, and (2) the sensitivity to NR2B-directed NMDAR antagonists
usually decreases (for review, see e.g. Köhr, 2006; but also section 3.3).
In neonatal wild-type mice, the presence of synaptic NR1/NR2B receptors was
suggested by the slowdown of NMDA EPSCs during Mg2+ washout exclusively
at negative potentials, although synaptic NR1/NR2B receptors failed to show
the distinct voltage dependence of NMDA EPSC decay time observed in adult
NR2A−/− mice. Therefore, in neonatal wild-type mice, we could not distinguish
whether CP-101,606 antagonized NR1/NR2B, NR1/NR2A/NR2B and/or other
NR2B-containing triheteromeric NMDARs, which may include NR2D or NR3 sub-
units, although their presence in CA1 pyramidal cells is still unclear (for review,
see Stephenson et al., 2008). In any case, these latter subunit combinations and/or
additional factors regulating NR1/NR2B receptor-mediated NMDA EPSC decay
time in neonatal wild-type mice implicate that NMDA EPSC decay time ratios are
constant over development, since NR1/NR2B receptors are a minor population in
adult synapses.
The existence of triheteromeric NMDARs in adult mice raises the question as
to their function. Since it is impossible to examine this NMDAR population in
isolation, the role of NR1/NR2A/NR2B receptors remains speculative. Presence
of NR2B within synaptic NMDARs could be essential at all developmental stages,
as NR2B, compared to NR2A, allows binding with higher affinity to molecules
important for NMDAR signaling or internalization, e.g. CaMKII (Barria and
Malinow, 2005; Bayer et al., 2001), rasGRF1 (Kim et al., 2005; Krapivinsky et
al., 2003) or the clathrin adaptor protein AP-2 (Roche et al., 2001). Regarding
synaptic plasticity in hippocampal synapses, magnitude of NMDAR-dependent
LTP and charge transfer during induction by low frequency stimulation correlate
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(Berberich et al., 2007). Presence of NR2B in NR2A−/− mice preserves LTP
(Kiyama et al., 1998), but LTP is impaired in NR2B-lacking CA1 neurons of
NR2B∆Fb mice (von Engelhardt et al., 2008). Thus, we propose that presence of
NR2B within NR1/NR2A/NR2B receptors in adult wild-type mice is crucial for
charge transfer during hippocampal LTP induction, learning, and memory.
3.2 Evidence for triheteromeric NMDA receptors
at different synapses in the CNS
Our study identifies triheteromeric NR1/NR2A/NR2B receptors to represent a
prominent NMDAR population in adult hippocampal synapses. We characterized
this major population by the new combination of voltage dependence of decay and
decay time. This observation suggests that also other triheteromeric NMDARs
could have unique receptor properties and thus expand the diversity of NMDAR
function.
In heterologous expression systems, coexpression of different NR2 subunits with
the NR1 subunit resulted in formation of triheteromeric NMDARs. Examin-
ing the concentration-response curves to glycine in Xenopus oocytes coexpressing
NR1, NR2A, and NR2C revealed that a triheteromeric receptor containing all of
these subunits is preferentially formed (Wafford et al., 1993). In Chinese hamster
ovary cells transfected with NR1, NR2A, and NR2B, single-channel recordings on
outside-out patches exposed a small number of cells with properties intermediate
to NR1/NR2A and NR1/NR2B, including insensitivity to CP-101,606 but redox
properties similar to NR1/NR2B. This was interpreted to be consistent with the
coassembly of NR2A with NR2B (Brimecombe et al., 1997). In addition to trihe-
teromeric NR1/NR2 receptors, the NR3 subunit has been shown in heterologous
expression systems to assemble in a triheteromeric complex of NR1, NR2, and
NR3 to form an NMDAR with novel properties and attenuated currents compared
to NR1/NR2 NMDARs (for review, see Henson et al., 2010).
Using various approaches, different subtypes of triheteromeric NMDARs com-
bining different NR2 subunits have been described in several brain regions in ad-
dition to CA3-to-CA1 synapses. The investigation of somatic NMDARs in new-
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born rat hippocampal granule cells by single-channel recordings of outside-out
patches suggested that NMDARs in P0 hippocampal granule cells are a mixture of
NR1/NR2B and triheteromeric NR1/NR2B/NR2D receptors. This was concluded
from the consideration of the biophysical properties of the channel, namely the
pattern of single-channel activity, and the sensitivity to ifenprodil (Piña-Crespo
and Gibb, 2002).
NR1/NR2B/NR2D as well as NR1/NR2A/NR2D have been discovered by im-
munoprecipitation in rat thalamus, cortex, and midbrain (Dunah et al., 1998).
Accordingly, NR1/NR2B/NR2D receptors have been described to exist in rat sub-
stantia nigra dopaminergic neurons. A combination of single-channel recordings
and pharmacological approaches was used to identify somatic NR1/NR2B/NR2D
receptors (Jones and Gibb, 2005), and these receptors have also been shown to form
a significant fraction of synaptic NMDARs (Brothwell et al., 2008). In the latter
study, electrophysiological recordings were performed in acute midbrain-containing
slices and the effect of different pharmacological drugs on NMDA EPSCs was used
to conclude for the subtypes present in synapses. However, the decrease of NMDA
EPSC time constants over development as well as the developmental profile of
NR2D mRNA expression did not support the concluded synaptic NMDAR com-
position.
Furthermore, the comparison of NMDAR channel activity in cerebellar Golgi
cells in acute cerebellar slices from wild-type and NR2D−/− mice (P7-P10) sug-
gests that triheteromeric NR1/NR2B/NR2D receptors are present in Golgi cells of
wild type, but that this receptor subtype is restricted to extrasynaptic sites (Brick-
ley et al., 2003). In contrast, Didier et al. (1995) reported that only low levels of
NR2D mRNA can be detected by in situ hybridization in cerebellar nuclei, the
Purkinje layer, and the molecular layer over development. They performed addi-
tional immunoprecipitation experiments and consequently proposed that, at early
stages, the predominant NMDAR subtype includes NR1, NR2A, and NR2B in the
same complex. However, another study described the existence of NMDARs in the
adult mouse cerebellum with a pharmacological profile similar to that displayed
by the coexpression of NR1/NR2A/NR2C subunits in human embryonic kidney
293 cells (Chazot et al., 1994).
In contrast to the divergent results concerning triheteromeric NMDARs in the
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cerebellum, triheteromeric NR1/NR2A/NR2B in the cortex have consistently been
reported by both biochemical and electrophysiological studies, but their proportion
of the total NMDAR population is still unclear (Kew et al., 1998; Luo et al., 1997;
Sheng et al., 1994).
In a recent study, it was postulated that the mature NMDAR subtype at
the calyx-of-Held-medial nucleus of the trapezoid body synapse is a trihetero-
meric NR1/NR2A/NR2C receptor (Steinert et al., 2010). The conclusion that
the NMDAR population at this synapse consists rather of a single triheteromeric
receptor subtype than of two independent diheteromeric NMDAR populations is
based on the observation that the slow and the fast component of the decay time
constant describing the biphasic decay kinetics showed similar pharmacology and
age-dependent changes. However, outside-out patches from cells expressing exclu-
sively recombinant NR1/NR2A receptors decay in a biphasic manner and the fast
and the slow components have been shown to arise from the simultaneous deacti-
vation of receptors that gate with short and long openings, respectively (Zhang et
al., 2008). Thus, effects on the two components of the decay time constant might
not necessarily be related to the NMDAR population present in a synapse.
In summary, triheteromeric NMDARs including two NR1 and two different NR2
or NR3 subunits with properties distinct from diheteromeric NMDARs contribute
to synaptic transmission at different synapses in the CNS.
3.3 NR2B-directed antagonists and related issues
The postnatal appearance of NR2A in many brain areas is often correlated to a
decrease in the sensitivity of NMDA EPSCs to NR2B-directed antagonists (for
review, see e.g. Köhr, 2006). We also observed a developmental decrease in the
antagonist sensitivity of ifenprodil and CP-101,606 in wild-type mice as long as
we recorded NMDA EPSCs in the presence of Mg2+. This was not observed in
the absence of Mg2+ and suggested that recording conditions influence the sensi-
tivity of both NR2B-directed NMDAR antagonists in slices. We confirmed this
possibility for CP-101,606 in adult NR2A−/− mice, which lack NR1/NR2A and
NR1/NR2A/NR2B receptors, by showing that NMDA EPSCs were antagonized
stronger in absence than in presence of Mg2+. This influence of Mg2+ appears to be
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restricted to acute slices, since ifenprodil antagonized recombinant NR1/NR2B re-
ceptors to similar extents in absence and in presence of Mg2+ (Hatton and Paoletti,
2005). Consistent with our results in hippocampal slices, in cerebellar slices of P7
rats the extent of NMDA EPSC antagonism by CP-101,606 was never as strong
as that observed for recombinant NR1/NR2B receptors (≤70%, Rumbaugh and
Vicini, 1999). Yet, the 80% reduction of NR1/NR2B receptor-mediated NMDA
EPSCs by CP-101,606 observed under Mg2+-free conditions (≤4.5 µM) is close
to the maximal (80-90%) reduction of agonist evoked currents mediated by re-
combinant NR1/NR2B receptors (Mott et al., 1998; Williams, 1993). Thus, to
achieve maximal antagonism by NR2B-directed NMDAR antagonists in slices, ab-
sence of Mg2+ is recommended. This is particularly important when triheteromeric
NMDARs are present because in the presence of Mg2+ antagonism by CP-101,606
of NR1/NR2A/NR2B receptors is more constrained than that of NR1/NR2B re-
ceptors. This could be concluded from the observation that the reduction of the
CP-effect by Mg2+ was more pronounced in wild-type than in NR2A−/− mice.
NR2B-directed NMDAR antagonists fail to distinguish between NR1/NR2B
and/or NR1/NR2A/NR2B receptors. Both subtypes bind e.g. ifenprodil with
high affinity, but currents mediated by both subtypes are reduced to different
extents (Hatton and Paoletti, 2005). The ifenprodil derivatives CP-101,606 and
Ro25-6981, which have significantly higher affinity for NR1/NR2B receptors than
ifenprodil (Chazot et al., 2002; Fischer et al., 1997; Williams, 1993), were previ-
ously proposed to represent two classes of NR2B-directed NMDAR antagonists
(Chazot et al., 2002). Ro 25,6981 was found to bind with comparable high affini-
ties to both NR1/NR2B and NR1/NR2A/NR2B receptors (Hawkins et al., 1999),
whereas binding of CP-101,606 was significantly reduced by the presence of another
NR2 subunit within the NMDAR complex (Chazot et al., 2002). Unfortunately,
this distinction did not apply when examining the decrease of NMDA EPSCs by
CP-101,606 in wild-type mice. The 50% reduction of NMDA EPSCs by CP-101,606
in the absence of Mg2+ in P28 wild-type mice demonstrates that CP-101,606 blocks
NR1/NR2A/NR2B receptors besides NR1/NR2B receptors. Therefore, ifenprodil
and its derivatives are NR2B-directed, but not NR1/NR2B-selective antagonists.
Furthermore, the 50% reduction of NMDA EPSCs by CP-101,606 identifies trihe-
teromeric NMDARs as the foremost NMDAR subtype (>50%) in adult synapses,
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since maximal antagonism of NR1/NR2B receptors is 80-90% (Mott et al., 1998;
Williams, 1993), and the extent of antagonism is reduced for NR1/NR2A/NR2B
receptors (Hatton and Paoletti, 2005).
In wild type, inhibition of the slow decaying NR1/NR2B receptors by NR2B-
directed antagonists is expected to accelerate the NMDA EPSC deactivation. As
NR2B-directed antagonists have been reported to act in a voltage-independent
manner (Mott et al., 1998; Williams, 1993), the effect on NMDA EPSC deacti-
vation is anticipated to be similar at negative and positive membrane potentials.
However, we observed in our experiments that CP-101,606 accelerated the deac-
tivation exclusively at +40 mV and not at −40 mV, although NMDA EPSC am-
plitudes were similarly reduced at both membrane potentials (see also Punnakkal
et al., 2006). Usually, effects of NR2B-directed antagonists on NMDA EPSC de-
cay are investigated exclusively at negative or at positive membrane potentials.
Accordingly, ifenprodil has been described to accelerate the NMDA EPSC decay
at +40 mV (Bellone and Nicoll, 2007; de Marchena et al., 2008), but the NMDA
EPSC decay at −40 mV has not been altered by ifenprodil (Kirson and Yaari,
1996) or CP-101,606 (Longordo et al., 2009).
The CA3-to-CA1 synapse is well established for the investigation of molecular
processes underlying learning and memory, and the role of NMDARs in physiolog-
ical and pathological conditions has been widely studied. Nevertheless, the actual
subunit composition of these receptors in the hippocampal circuit has been not as-
certained yet. The study presented here offers a better understanding of NMDARs
at this synapse by identifying triheteromeric receptors as being the major play-
ers in mature CA3-to-CA1 connections. Our findings extend the understanding
of NMDAR function during physiological synaptic transmission and have to be
considered for the design of new pharmacological strategies to precisely target
a specific subtype in order to counteract the deleterious effects of pathological
NMDAR function.
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4 Materials and Methods
4.1 Mouse genotyping
The tips of mouse tails were digested by proteinase K (1 mg/ml) in TENS buffer
(50 mM Tris-HCl pH 8.0, 100 mM EDTA, 100 mM NaCl, 1% SDS) at 55◦C. After
precipitation in one volume of isopropanol and washing with 70% ethanol, genomic
DNA was diluted by shaking for 30 min in 300 µl of sterile H2O (Millipore) at 55◦C.
For PCR analysis, 1 µl of this solution was used to perform the PCR reaction as
detailed below.
PCR-protocol for genotyping NR2A−/− mice
PCR-mix for 10 PCR reactions:
PCR-buffer [10 x] 25 µl
MgCl2 [50 mM] 10 µl
dNTPs [20 mM] 10 µl
primer PGK Prom2 [10 µM] 5 µl
primer 2AIN10N∗do [10 µM] 5 µl
primer 2AIN11x∗up [10 µM] 10 µl
H2O 174 µl
Taq Polymerase 1 µl
PGK Prom2: 5’-CAGACTGCCTTGGGAAAAGCG-3’
2AIN10N∗do: 5’-GGGAATTCGCGGCCGCAAGAGCAAGAAGACTCC-3’
2AIN11x∗up: 5’-GGAGGTACCTCGAGCTCTTCTACAG-3’
PCR: 24 µl PCR-mix + 1 µl DNA-Preparation
PCR-protocol:
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Temp. Time
96◦C 3 min
96◦C 20 s
55◦C 30 s 35 cycles
72◦C 75 s
72◦C 10 min
Expected Bands:
NR2A WT: about 580 bp
NR2A−/−: about 1100 bp
PCR-protocol for genotyping NR2B∆Fb mice
PCR-mix for 10 PCR reactions:
PCR-buffer [10 x] 62.5 µl
MgCl2 [50 mM] 25 µl
dNTPs [20 mM] 25 µl
2 B 3’ [10 µM] 12.5 µl
2 B 5’ [10 µM] 12.5 µl
H2O 460 µl
Taq Polymerase 2.5 µl
2 B 3’: 5’-GAGTTGCCTCCATCATTGTGTC-3’
2 B 5’: 5’-AGTCTCCTCTTCATCCTCAGTG-3’
PCR: 24 µl PCR-mix + 1 µl DNA-Preparation
PCR-protocol:
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Temp. Time
95◦C 1 min
95◦C 15 s
55◦C 20 s 35 cycles
72◦C 30 s
72◦C 5 min
Expected Bands:
NR2B WT: about 213 bp
NR2B∆Fb: about 329 bp
All animals were re-genotyped following experiments.
4.2 Slice preparation
All experimental procedures were in accordance with the animal welfare guidelines
of the Max Planck Society. Deeply anesthetized (isoflurane; Baxter, Germany)
wild-type (WT, C57Bl/6), NR2A−/− (Sakimura et al., 1995), and NR2B∆Fb mice
(von Engelhardt et al., 2008) (P5, P4-P6; P28, P27-P29 or P44, P41-P48) were
decapitated and their brains were removed. For neonatal (P5) mice, coronal hip-
pocampal slices (250 µm) were prepared using artificial cerebrospinal fluid (ACSF)
containing (in mM): 125 NaCl, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 1 MgCl2, 25
glucose, 2 CaCl2 (Biometra, Göttingen, Germany); bubbled with 95% O2/5% CO2
(pH 7.3, 320 mOsm). The cerebellum, olfactory bulb, and part of the prefrontal
cortex were removed with a razor blade. The brain was glued (cyanoacrylate glue;
UHU, Germany) with the cut surface of the prefrontal cortex onto a metal plate,
which was then tightly fixed in a slicing chamber. For adult (P28/P44) mice,
transverse hippocampal slices were prepared using either a modified ACSF con-
taining (in mM): 125 NaCl, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 6 MgCl2, 25
glucose, 1 CaCl2, 3 myo-Inositol, 2 Na-pyruvat, 0.4 vitamin C, or a slicing solution
containing (in mM): 140 K-gluconate, 10 HEPES, 15 Na-gluconate, 0.2 EGTA, 4
NaCl (pH 7.2); both bubbled with 95% O2/5% CO2. First, the cerebellum was
removed with a razor blade, then, the hemispheres were separated along the mid-
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line. One hemisphere was placed on the cut surface and 1-2 mm of the apical
cortex was removed by a cut perpendicular to the midline. The hemisphere was
glued (cyanoacrylate glue; UHU, Germany) with the cut surface facing down onto
a metal plate, which was then tightly fixed in a slicing chamber. The slices were
prepared at 4◦C using a vibratome (Sigmann Elektronik, Hüffenhardt, Germany)
with a razor blade at an angle of 12◦ to horizontal. Slices were transferred to a
recovery chamber filled with oxygenated ACSF, recovered for one hour at 35◦C
and were maintained at room temperature (22-25◦C) up to 8 hours after slicing.
4.3 Electrophysiology
4.3.1 Patch-clamp technique
The patch-clamp technique developed by Neher and Sakmann and originally used
for single-channel current recordings allows the recording of the electrical activity
of individual neurons (Brenner and Sakmann, 1978; Hamill et al., 1981; Neher and
Sakmann, 1976). The main principle is that a tight seal (giga-seal) is formed be-
tween a glass pipette and the membrane of a neuron. This so-called cell-attached
configuration critically minimizes electrical background noise and therefore allows
measuring of small currents and voltages (in the range of picoampere and micro-
volt) that are involved in neuronal activity. The cell-attached configuration can
be converted into different configurations enabling the measurement and control
of electrical acitivity. The whole-cell configuration permits recording of either
transmembrane currents if the voltage is kept constant (voltage-clamp mode) or
of changes in the membrane potential resulting from current flow via ion channels
if a constant current is applied (current-clamp mode).
Briefly, the patch-clamp amplifier is set to voltage-clamp mode and a command
voltage pulse of −5 mV and 10 ms duration is applied to the electrode. Positive
pressure is applied to the pipette to keep the tip clean when entering the bath
solution and the slice. The resistance of the pipette can be calculated by Ohm’s
law using the amplitude of the current response to the −5 mV voltage step. Under
visual control, the pipette tip is targeted through the slice to the soma of a visually
identified neuron. The pipette tip is slowly brought close to the soma until a
Materials and Methods 49
small dimple on the cell membrane becomes visible. Then, the positive pressure is
released and slight suction is applied. The membrane starts to seal onto the pipette
tip, which can be monitored in the electrical current recording: the current from
the pipette tip decreases rapidly because of the formation of a tight seal between
the pipette tip and the cell membrane. When almost no measurable current is
flowing, the giga-seal with a resistance between the pipette and the bath solution
in the order of GΩ is established. Capacitive currents arising by the applied
voltage step to the cell membrane are compensated. The voltage command is set
to −70 mV and after the establishment of the giga-seal, the membrane below the
pipette tip is disrupted by applying a transient suction pulse. The contact between
the electrode and the cytoplasm of the cell determines the series resistance (Rs),
whereas the passive electrical properties of the cell determine the input resistance
(Ri).
4.3.2 Patch-clamp setup
Electrophysiological recordings from CA1 hippocampal neurons were performed
with the patch-clamp amplifier EPC-9 (HEKA, Lambrecht, Germany) operating
in voltage-clamp mode.
Acute hippocampal slices were placed in a recording chamber constantly perfused
with oxygenated ACSF and fixed by a grid made of a platinum frame spanned
with dental floss. Hippocampal CA1 pyramidal neurons were visualized using an
upright fixed-stage microscope (Axioskop 1; Zeiss, Göttingen, Germany) equipped
with a 5x objective (Plan-NEOFLUAR; Zeiss), a 60x water immersion objective
(LUMPlanFl; Olympus, Tokyo, Japan) and an infrared-sensitive video camera
(C2400; Hamamatsu, Japan) combined with a 1.6x magnification. The preampli-
fier headstage holding the patch pipette and the stimulation pipette holder were
mounted on motorized micromanipulators (Mini 25; Luigs&Neumann, Ratingen,
Germany). Extracellular stimulation in stratum radiatum was performed with
a stimulus isolator (WPI, Saratosa, USA). Patch and stimulation pipettes were
pulled from thick-walled (0.5 mm) borosilicate glass capillaries (Hilgenfeld, Mals-
feld, Germany) on a horizontal pipette puller (P-97; Sutter Instruments, Novato,
CA, USA). The micromanipulators together with the recording chamber were
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mounted on a motorized xy-translation table to allow movement of the sample
and the pipettes below the fixed optical axis of the microscope. The extracellu-
lar solution was grounded with an Ag/AgCl pellet via the reference input of the
preamplifier headstage. The solution in the pipettes was in electrical contact with
the preamplifier via a chlorinated silver wire.
The optical and mechanical instruments were mounted to a vibration-isolation
table (Physik Instrumente, Karlsruhe, Germany) to minimize vibrations and were
surrounded by a Faraday cage in order to minimize electrical noise during the
recordings.
4.3.3 Synaptic current recordings
Single slices were transferred from the recovery chamber to the recording chamber
and continuously perfused with oxygenated ACSF containing 10 µM Bicuculline
methiodide or 5 µM Gabazine, 10 µM NBQX and 10 µM glycine. CA1 pyramidal
neurons were identified due to their characteristic morphology by using infrared
differential interference contrast microscopy. Patch pipettes had resistances of 3.5-
6.5 MΩ when filled with (in mM): 125 Cs-gluconate, 20 CsCl, 10 NaCl, 10 HEPES,
0.2 EGTA, 4 MgATP, 0.3 Na3GTP, 2.5 QX-314Cl− (pH 7.3, 270-320 mOsm).
Liquid junction potential was not corrected. Series and input resistances were
continuously monitored by measuring peak and steady-state currents in response to
hyperpolarizing pulses (−5 mV, 20 ms), and cells were excluded if series resistance
changed by more than 20%.
Pharmacologically isolated NMDA EPSCs were evoked in CA1 pyramidal cells
by electrical stimulation of Schaffer collaterals at 0.1 Hz in stratum radiatum about
150 µm distant from the CA1 cell body layer with monopolar glass pipettes filled
with 1 M NaCl. NMDA EPSCs were recorded at −40 and +40 mV in the presence
of 1 mM Mg2+ (ACSF) or following 25 minutes of Mg2+ washout using nominally
Mg2+-free ACSF (in mM): 125 NaCl, 25 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 25
glucose, 2 CaCl2 (pH 7.3, 310 mOsm). During Mg2+ washout, electrical stimulation
was preserved at 0.1 Hz. The Mg2+ concentration was 1.5 µM in freshly prepared
Mg2+-free ACSF and ≤4.5 µM in ACSF collected following 25 minutes of slice
perfusion (ICP-optical emission spectrometry by Christian Scholz, University of
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Heidelberg). In the absence of Mg2+, I-V curves were linear between −40 mV and
+40 mV, and raising the temperature from room temperature (22-25◦C) to near
physiological temperature (31-33◦C) had no effect on both reversal potential and
peak amplitudes (Fig. 14). Consequently, experiments were performed at room
temperature. In some experiments, the NMDAR antagonist D-APV (Biotrend)
or one of the two NR2B-directed antagonists CP-101,606 (Pfizer) or ifenprodil
(Sigma) were present. NR2B-directed NMDAR antagonists were washed in for 20
minutes either in the presence or absence of Mg2+ before their effects on NMDA
EPSCs were determined.
Fig. 14: I-V curves recorded in the absence of Mg2+ at room temperature
and at near-physiological temperature. I-V curves were recorded at room temper-
ature (blue) and near-physiological temperature (red) in 20 mV steps from -80 mV to
+60 mV and normalized to the respective peak amplitude at +40 mV. Peak amplitudes
at all membrane potentials were not different at room temperature (n = 17) and at near
physiological temperature (n = 9, p > 0.05 for all membrane potentials). Inset shows
representative I-V curves from −80 mV to +40 mV in 20 mV steps at room temperature
(left, blue) and near-physiological temperature (right, red) recorded in the same cell.
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4.3.4 Data acquisition and analysis
Synaptic responses were filtered at 3 kHz and digitized at 10 kHz using the AD-
converter of the EPC-9 (ITC-16; Instrutech, Great Neck, NY, USA). The am-
plifier and the ITC-16 were controlled by Pulse/Patchmaster software (HEKA,
Lambrecht, Germany) on a Macintosh Power PC (Apple, Cupertino, CA, USA).
Visually identified polysynaptic NMDA EPSCs were excluded and monosynap-
tic currents were averaged over 1.5 minutes of recording. The programs Pulse-
fit/Fitmaster were used for off-line analysis of peak amplitudes and decay time.
Averaged NMDA EPSCs were fitted biexponentially (Zhang et al., 2008), and
weighted Taus (ms) were calculated using following formula:
Tauweighted = (Ifast/(Ifast+Islow))*Taufast + (Islow/(Islow+Ifast))*Tauslow, where I
is the amplitude of the fast or slow component, and Tau is the respective decay
time constant (Stocca and Vicini, 1998). For each cell, at least two Tauweighted
were averaged for each recording condition, before the voltage dependence of de-
cay was estimated by the ratio Tauweighted at −40 mV divided by Tauweighted at
+40 mV. Data are presented as mean ± SEM. Statistical significance was evalu-
ated by paired (#,†) or unpaired (∗) Student’s t-tests, and ANOVA with Fisher’s
LSD post-hoc analysis. p < 0.05 was regarded as significant.
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5 Abbreviations
ACSF artificial cerebrospinal fluid
AMPA L-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
AMPAR AMPA receptor
BMI bicuculline methiodide
C Celsius
CA cornu ammonis
Ca2+ calcium
CaMKII Ca2+/calmodulin-dependent protein kinase II
Cl− chloride
CNS central nervous system
CTD carboxy-terminal domain
D-AP5 (D)-2-amino-5-phosphonopentanoate
DG dentate gyrus
EDTA ethylene diaminetetraacetic acid
GABA γ-aminobutyric acid
EC entorhinal cortex
EPSC excitatory postsynaptic current
EPSP excitatory postsynaptic potential
et al. et alii
e.g. for example
Fig. figure
G-protein guanosine nucleotide-binding protein
GluA-1/2/3/4 AMPA receptor subunit 1/2/3/4
GluK-1/2/3/4/5 Kainate receptor subunit 1/2/3/4/5
GluN1/2/3 NMDA receptor subunit 1/2/3
GluR glutamate receptor
Hz Hertz
I current
i.e. id est
54 Abbreviations
iGluR ionotropic glutamate receptor
IPSP inhibitory postsynaptic potential
K+ potassium
KA kainate
LBD ligand-binding domain
LPP lateral perforant-path
LTD long-term depression
LTP long-term potentiation
µ micro
m milli
M membrane (domain)
M Mol
m/s meter/second
Mg2+ magnesium
mGluR metabotropic glutamate receptor
MPP medial perforant-path
n nano
N asparagine
Na+ sodium
NBQX 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo-(F)-quinoxaline
NMDA N-methyl-D-aspartate
NMDAR NMDA receptor
NR1 NMDAR subunit 1
NR2A/B/C NMDAR subunit 2A/B/C
NR3A/B NMDAR subunit 3A/B
NTD amino-terminal domain
Ω Ohm
Osm Osmol
P postnatal
PCP phencyclidine
PSD postsynaptic density
Q glutamine
R arginine
Abbreviations 55
RNA ribonucleic acid
s second
S segment
Sb subiculum
SEM standard error of the mean
V Volts
WT wild type
Zn2+ zinc
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